POPULARITY
40 episodes with healthbox
3 episodes with healthbox
2 episodes with healthbox
Guest: Dr. Sean B. Rourke, neuropsychologist at St. Michael's Hospital Smart vending machines have launched on Canada's East coast. They're the first of what will be 100 nationwide. But instead of dispensing chocolate or candy, these machines hold life-saving supplies like HIV tests, naloxone kits and unused needles. They're called Our Healthbox and they're designed to reach communities underserved by traditional health care. Today, we're joined by Dr. Sean Rourke, a clinical neuropsychologist and scientist with MAP Centre for Urban Health Solutions at St. Michael's Hospital, who is leading the initiative. You can learn more about OurHealthbox and whether your community is eligible for a Healthbox here: https://www.ourhealthbox.ca/ Sources: CBC This episode was produced by Alexis Green, Saba Eitizaz and Paulo Maurqes.
The world has gone digital. How are you adapting? In this episode, we are sitting down with Julie Campbell, VP of Healthbox to talk about digital strategy. Healthbox, a HIMSS solution, supports and advises orgs that are developing, adopting, and investing in the digital solutions that will transform healthcare. How do our preconceptions about seniors, Medicaid, cybersecurity, EMR/EHRs, and digital strategy influence our progress towards the ideal digital health ecosystem? Join us as we walk through the myths holding back digital transformation and how we can use the Digital Health Indicator (DHI) to build a plan to overcome them in the post-COVID world.
Alyssa Jaffee is a Partner at 7wireVentures, a digital health-focused venture capital firm, where she invests in technology and technology-enabled services that empower consumers to become better stewards of their health. She currently sits on the board of Ayogo Health and Higi and is a board observer with Zerigo Health, NOCD, Jasper Health, RecoveryOne, Brightline, and MedArrive. Alyssa's prior experience in venture capital includes as an investor at Pritzker Group Venture Capital, Hyde Park Angels, and Healthbox. She was also the co-founder of TransparentCareer, a company focused on helping people make more data-driven career decisions. Alyssa also served as Senior Director at the Advisory Board Company, where she was responsible for expanding new business through the sales of technology platforms.
Alyssa Jaffee is a Partner at 7wireVentures where she focuses on investments in digital healthcare and technology-enabled services that empower consumers to be better stewards of their health in today's changing healthcare ecosystem. Alyssa sits on the board of Ayogo Health and Higi and is a board observer with Zerigo Health, NOCD, Jasper Health, and RecoveryOne. Alyssa's prior experience in venture capital includes her time as an investor at Pritzker Group Venture Capital, Hyde Park Angels, one of the Midwest's largest angel organizations, and Healthbox, an early-stage healthcare innovation firm, supporting their accelerator program called the Studio. Alyssa is also a Co-Founder of TransparentCareer, a 2016 NVC winning company focused on helping people make more data-driven career decisions. Alyssa holds a bachelor's degree in Marketing and Spanish from the University of Wisconsin-Madison and an M.B.A. from the University of Chicago – Booth School of Business. In this episode, Alyssa discusses her career path into digital healthcare investing and what she looks for when making investments. --- Support this podcast: https://anchor.fm/theia-hc/support
Guest Bio:Reid Robison is the co-founder and medical director of Cedar Psychiatry. He is also a founding board member at the Utah-based non-profit Psychedelic Institute. Dr. Robison serves as Coordinating Investigator of the MAPS (Multidisciplinary Association for Psychedelic Studies) MDMA-Assisted Psychotherapy study of Eating Disorders, supervising the training and clinical research of all of the MDMA therapy sites. Additionally, he works in a medical and therapeutic capacity at psychedelic medicine retreats abroad, and often consults on medical safety issues and plant medicine use.Reid was born in Chicago, but grew up in Toronto, Canada. He completed undergraduate studies in Neuroscience at Brigham Young University, and went on to medical school at the University of Utah where he earned both his MD and MBA degrees. After residency training in Psychiatry at the University of Utah, Dr. Robison completed fellowship training in Neurodevelopmental Genetics, followed by a postdoc in Bioinformatics. He currently serves as adjunct faculty at both the University of Utah and Brigham Young University.Dr. Robison has extensive experience with ketamine in both research and clinic settings. In 2011 he conducted his first research study with ketamine, then went on to create a ketamine program for treatment-resistant depression at Intermountain's IV Therapy Center at IMC. Dr. Robison was selected as Principal Investigator for Utah by J&J/Janssen to run a site for a pivotal IV-ketamine treatment-depression study, leading to the company's FDA approval of Spravato (esketamine) via breakthrough therapy designation earlier this year. In 2013, the Intermountain Research & Medical Foundation awarded an investigator-initiated grant to Dr. Robison to continue studying ketamine for depressive disorders. Dr. Robison also conducted an IRB-approved study of ketamine for depression and severe eating disorders at Center for Change. He continues to supervise the ketamine therapy practice at Cedar Psychiatry, and believes in careful but prudent use of ketamine as a tool for transformation in severe depression, PTSD, OCD and other mental health conditions.Dr. Robison joined the tenure-track faculty at the University of Utah, conducting industry sponsored and investigator initiated trials of new neuropsychiatric medicines and co-directed a genetics lab. He went on to co-found three healthcare startups that were all acquired. First came Clinical Methods, a phase I-IV CNS clinical trials site, where Dr. Robison led over $15 million in industry-sponsored studies as Principal Investigator, which was acquired by CRI-Lifetree (and later PRA Healthsciences, NASDAQ: PRAH). Next Dr. Robison co-founded Anolix, a healthcare data analytics firm dedicated to answering questions for big pharma using machine learning and big data. He then co-founded Tute Genomics, a personalized medicine software company that raised over $10 million in venture capital from various investment partners including Tencent, Intermountain Healthcare, Peak Ventures and more. As CEO of Tute, Dr. Robison was selected to participate in numerous startup incubators and accelerators such as BoomStartup, Healthbox and StartupHealth.Reid shares his vision for personalized medicine whenever he gets the chance, like in his TEDx talk on the Genome Revolution.Dr. Robison is active in humanitarian pursuits, and was part of the University of Utah's Global Health Initiative, where he made medical trips to post-quake Haiti, refugee camps along the Thai-Burma border and rural Ghana. He also founded the Polizzi Clinic, a free mental health clinic based in Salt Lake City, Utah, and served as Psychiatrist for Utah Health & Human Rights, helping refugees and human trafficking subjects.Dr. Robison set up the Consult-Liaison Service at Intermountain Medical Center, Intermountain's flagship hospital, providing psych consults to the ER and medical floors. He currently serves as Medical Director at Center for Change, one of the top Eating Disorder treatment centers worldwide.Dr. Robison is a firm believer that inside every person, no matter where they are in their journey, is an inextinguishable light with the capability for a full human life. Dr. Robison says, “Not all wounds are visible, and everyone has their unique struggle. Pain is real…but so is hope.”
Gail Peace started her business journey early. At 12 - having never worn makeup - she began selling Avon to women in the neighborhood because it was much more lucrative than babysitting. Today she's the CEO of Ludi, a physician time tracking software based in Nashville TN. Today she talks about life as a CEO, going through the accelerator program Healthbox, seeking venture capital, building a team, and the challenges of being a female founder.
Host Matt Fisher guest is Justin Gernot, Vice President of Healthbox. They discuss the history of innovation and how to define innovation; culture change for commitment to innovation; necessity as drive for willingness to adapt; and importance of strategy in driving success. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play HealthcareNOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/
Investor Connect is proud to introduce a brand new Podcast series: Investor Perspectives. In this, our last episode of part one of our series, we conclude our discussion on the Impact of the COVID-19 Economy on Startup Funding with experienced investors from the TEN Capital network. In today’s installment, we’re focusing on what new investment thesis the COVID-19 pandemic will bring, and what startup sectors will be diminished or eliminated by COVID-19. Today’s episode features insights from: Evan Cohen of Healthbox - 0:42Kevin King of Texas Halo Fund - 6:39Rodolfo Dieck of Proeza Ventures - 13:02Dan Kerr of Flyover Capital - 20:56Yaniv Sneor of Mid Atlantic Bio Angels - 26:23Gary Trauner of Silicon Couloir - 33:01 We hope you enjoy listening to this informative new series. _____________________________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: Check out our other podcasts here: For Investors check out: For Startups check out: For eGuides check out: For upcoming Events, check out For Feedback please contact info@tencapital.group
Investor Connect is proud to introduce a brand new Podcast series: Investor Perspectives. Over the next few weeks, we continue our discussion on the Impact of the COVID-19 Economy on Startup Funding with experienced investors from the TEN Capital network. In today’s installment, we’re focusing on what our investors are doing to prepare for the market after the lockdown and what their new investment thesis is. Today’s episode features insights from: Evan Cohen of Healthbox 0:42Kevin King of Texas Halo Fund 6:39Rodolfo Dieck of Proeza Ventures 12:07Dan Kerr of Flyover Capital 15:52Yaniv Sneor of Mid Atlantic Bio Angels 17:05Gary Trauner of Silicon Couloir 19:23 We hope you enjoy listening to this informative new series. _____________________________________________________________________________________________ For more episodes from Investor Connect, please visit the site at: Check out our other podcasts here: For Investors check out: For Startups check out: For eGuides check out: For upcoming Events, check out For Feedback please contact info@tencapital.group
Through its Healthbox subsidiary, HIMSS is facilitating peer-to-peer sharing of COVID-19 technology solutions and lessons learned on the COVID-19 Digital Think Tank. On today's HIMSSCast, host Jonah Comstock chats with Healthbox President Neil Patel about how to use the platform, how it came about, and what he's seen on it so far.Neil and Jonah also get to talking about the effect the current crisis has had on telemedicine adoption, and how that might look when this is all over.Check out the Think Tank for yourself here: https://www.himss.org/news/covid-19-digital-think-tank
On this episode of The Handoff, Dan speaks with Chuck Feerick about how Clarify Health Solutions is using data to create actionable impact on the healthcare industry. Chuck shares how Clarify is approaching the critical issue of patient to provider mapping using “outside-in analytics” that combine Medicare, Medicaid and commercial data. He talks about the difference between good and bad data, how Clarify involves clinicians in its process and how the company's data is being used to give providers and payers a lens into their performance. Chuck is the Solutions Lead at Clarify Health, an analytics and software company that enables health systems to deliver better outcomes and higher value care. Over the course of his career, he has worked in a variety of different settings in healthcare, including consulting, venture capital and product management. He also formerly hosted the Innovation Rising Podcast, presented by Healthbox. Chuck is also passionate about health and wellness at both the community and individual level. As an ACE Certified Personal Trainer, he designed and built a holistic wellness program for a 6,000+ employee organization across 14 states. He is also the Founder of StandUp Chicago, a non-profit volunteer organization working to help schools implement standing desks in their classroom for their students. The transcript for this episode can be found here: www.trustedhealth.com/the-handoff-podcast/episode-8-chuck-feerick
On this episode of The Handoff, Dan speaks with Chuck Feerick about how Clarify Health Solutions is using data to create actionable impact on the healthcare industry. Chuck shares how Clarify is approaching the critical issue of patient to provider mapping using “outside-in analytics” that combine Medicare, Medicaid and commercial data. He talks about the difference between good and bad data, how Clarify involves clinicians in its process and how the company's data is being used to give providers and payers a lens into their performance. Chuck is the Solutions Lead at Clarify Health, an analytics and software company that enables health systems to deliver better outcomes and higher value care. Over the course of his career, he has worked in a variety of different settings in healthcare, including consulting, venture capital and product management. He also formerly hosted the Innovation Rising Podcast, presented by Healthbox. Chuck is also passionate about health and wellness at both the community and individual level. As an ACE Certified Personal Trainer, he designed and built a holistic wellness program for a 6,000+ employee organization across 14 states. He is also the Founder of StandUp Chicago, a non-profit volunteer organization working to help schools implement standing desks in their classroom for their students. The transcript for this episode can be found here: www.trustedhealth.com/the-handoff-podcast/episode-8-chuck-feerick
In this episode, Hall welcomes Vik Sasi of Dreamers VC. Dreamers VC, founded by Will Smith and Keisuke Honda is a venture capital fund bridging established Japanese corporate investors with early-stage, US-based companies. The company was conceived from their shared passion to improve the world. They invest in innovative companies, alongside top-tier lead investors, to improve lives through the application of emerging technology. When appropriate Dreamers VC supports expansion by connecting companies to their global network of capital and strategic partners. Generally, they make the first investment into a Seed, A, or B round, and maintain follow on capital for the growth stages of our investments. Vik was previously on the investment team at AmFam Ventures. He began his career as an Analyst for the Clinton Foundation's Health Access Initiative and as a Strategic Advisor to the Haitian Ministry of Health, with additional stints in investment banking at Morgan Stanley and venture capital at Healthbox. In this episode, Hall and Vik speak about the Dreamer fund and what they specifically look for. According to Vik, Dreamers is a purely opportunistic fund. Nearly 100% of the deal flow is inbound. It all boils down to the team, organic growth and potential for uncapped upside. Vik also touches on what he sees as challenges startups face and offers his advice. It's really simple, just stay in your lane, run your race, try not to get caught up in trying to keep up with the Joneses.
As delivering care becomes more complicated, it can be difficult for providers to find joy in the work they do. Neil Patel, founder of HIMSS innovation services company Healthbox, discusses how tech vendors and providers can partner to identify key challenges, build solutions to address them and even fall in love with the problems they work to solve. Recorded at ACE 2019 In episode Subscribe to Newsletters Healthbox Insights and Newsletter Healthcare Tech Newsletter (Kevin O'Leary) The Weekly Gist (Gist Healthcare) MobiHealthNews Reach out to Neil at neil@healthbox.com
What does innovation look like in your system? Innovation in healthcare can come from anywhere and our clinical colleagues have a million ideas to bring forward. Most will never see the light of day because there is no process for it. Listen to Justin Gernot from Healthbox, the innovation advisory part of HIMSS, discuss what innovation looks like in top performing health systems.
In this episode we’re speaking with Chuck Feerick, former host of the Innovation Rising podcast presented by Healthbox. We have a great conversation about why he started a podcast, Innovation Risings unique podcast format and what’s next for his podcast career.
Meet Michael Sengbusch Since leaving Influence Health in 2017, Michael Sengbusch joined ATDC as the CTO-in-Residence. ATDC is Georgia's oldest, largest, and most influential startup incubator. At ATDC he mentors and advises over 40 startups in Atlanta. Michael continues to be actively involved in both healthcare and marketing technology. He will be speaking at Healthbox Studio in October on healthcare marketing topics. More info on ATDC: http://atdc.org ATDC Healthcare Technology Vertical: Georgia Tech to Launch Health Technology Initiative at the Advanced Technology Development Center. Healthbox Studio Healthbox Studio Report Twitter handle: @msengbusch1 On the Get Social Health podcast, Janet interviews Michael Sengbusch about Facebook and marketing for healthcare systems. Give a listen or review the transcript notes below: Janet: 00:00 Podcasting is a fun, yet sometimes time-consuming passion. As some of you may have noticed, I took a little hiatus from podcasting so I could focus on the launch of the Healthcare Marketing Network, a company that brings together healthcare companies with healthcare writers. I'll tell you more about the Healthcare Marketing Network at the end of the podcast. However, in taking my little leave of absence, I had previously recorded a few interviews that hadn't been published. Today's conversation is with Michael Sengbusch, a healthcare technology and marketing expert. In my intro, you'll hear that I mentioned where he was working at the time of the interview, but I've got a little update on Michael's career since we recorded this interview. Janet: 00:42 Michael Sengbusch, left Influence Health in 2017 and joined the advanced technology development center as their CTO in residence. ATDC is Georgia's oldest, largest and most influential startup incubator. Hosted by Georgia Tech at ATDC, Michael mentors and advises over 40 startups in Atlanta. He continues to be actively involved in both healthcare and marketing technology and will be speaking at Healthbox studio in October on healthcare marketing topics. Janet: 01:14 Now let's jump into our conversation, a Facebook, so needed for marketing yet such a challenge to manage for healthcare. Today I'm speaking with healthcare marketing and technology expert, Michael Sengbusch about Facebook tracking and CRM on Get Social Health. Announcer: 01:37 Welcome to Get Social Health, a conversation about social media and how it's being used to help hospitals, social practices, healthcare practitioners and patients connect and engage via social media. Get Social Health, brings you conversations with professionals, actively working in the field and provides real-life examples of healthcare, social media in action. Here is your host, Janet Kennedy on Get Social Health. Janet: 02:05 I've had the opportunity to talk to a lot of different people in my field, but occasionally I run across someone who we should have crossed paths ages ago. I don't know how I haven't met or talked to Michael Sengbusch. Yes, but the day is my day. I'm really excited about it. Michael is currently serving as the Influence Health senior VP and GM of Consumer Experience. Michael has established credibility through the healthcare industry as a thought leader in digital healthcare marketing and with expertise in leveraging Facebook as a successful patient acquisition channel. I know my listeners are going to be really excited about how that works. Welcome to Get Social Health, Michael. Michael: 02:48 Thanks for having me today. Janet: 02:49 All right. I want to jump right to how does Facebook bring patients in, but I think we need to set a few background stories here to get people up. Speed. So first off, do you mind sharing a little bit about your background and how you got into healthcare and social media? Michael: 03:07 That's actually kind of an interesting story. So my background is in technology and in computer science, so I've been kind of trained and spent the first half of my career as a software developer as an engineer and it kind of took that path and got more into product development and then sales and startups. And then I was at a startup. I was one of the early members of a company called bright whistle and we were doing digital marketing technology and we were exploring different spaces and we kind of stumbled upon a gap in a healthcare marketing technologies, particularly in the provider space with hospitals and so I don't think when we started that we decided to go attack healthcare marketing for healthcare providers, but we did kind of stumble into that based on some connections that we hadn't realized that it was an underserved area. Michael: 03:56 There was a lot of opportunity there and we decided to just go heads down and work on digital marketing for healthcare providers and health systems across the country and that's what was created as Bright Whistle which was acquired about two and a half years ago by Influence Health and I've stuck around here for the last couple of years and helped integrate those platforms together and it's really kind of a grown from there. Janet: 04:20 No, that's exciting. You actually survived an acquisition and ended up coming out on top, so congratulations to you. Tell me a little bit about the award that you won in 2014 at Bright Whistle. Michael: 04:32 One of the early things that we were doing was experimenting with Social Media Marketing and if you go back to 2000, 10, 2011, social media was new and social media marketing was extremely new and in healthcare it was bleeding edge if not unheard of. And so while we were doing a lot of search marketing and social marketing for, for health systems and hospitals, we were bringing that to the table and one of the reasons why we were able to do that kind of so early was we were one of the early companies that was building software and technology on top of the Facebook marketing API and when we worked with Facebook early on, the different marketing partners that they accepted in program all really had to have something unique and different about them. So you know, what were you going to bring to the table? Now some of these companies brought scale. They brought big advertisers, big dollars. We brought healthcare and that was just kind of a weird. It was, it was kind of weird for Facebook at the time. What are you guys doing in healthcare? That seems a little, it seems odd. Michael: 05:34 but that seems interesting because we know it's important. So we didn't represent a huge market share as it relates to marketing. We didn't drive a whole ton of advertising, but we brought a really interesting story to the table. So working really closely with Facebook to do marketing a technology. We participated in the 2014 Facebook innovation competition and that brings all the Facebook marketing partners together. People submit different case studies and applications from all across the globe. So there's thousands of Facebook marketing partners, and we were awarded the winner and in our category and we were able to win that for some of the really interesting marketing group doing it Facebook, but more importantly, not just the marketing, but what we were doing with the data and how we were actually measuring the results of those marketing campaigns. So, we won that by actually using Facebook targeting Facebook marketing and then tying that to a healthcare CRM to figure out attribution and figure out what type of marketing campaigns actually generated results in a clinical setting. Janet: 06:42 So that's really, really exciting. Now, is that still an operation? Is that part of the Influence Health program? Michael: 06:48 Yeah, that was actually the beginning stages of what we would call kind of our next generation CRM solution and CRM and healthcare has been something that's been changing a lot over the last few years and one of the key components to any kind of CRM system is being able to use that not just for the outbound targeting but also that consumer experience which happens after somebody responded to a marketing campaign. So how do I learn more about that person, how do I personalize that information and then how do I use the data that I have in the CRM system, clinical information, claims information, diagnosis information in order to learn more about how that person made the healthcare decision that they made and then which channels can I better communicate to them through that? Michael: 07:34 So that was kind of the early stages of what we call a healthcare CRM and that makes up a big portion of what we do here at Influence Health. Janet: 07:42 Well, I do want to ask you a question about CRM and crossover. So when you talk about CRM, you literally are talking about patient information, not a marketing database or the email lists that's used by the marketing team to send out the newsletter for the hospital. Michael: 08:00 Yeah, I think those start to bleed together. So in a sense, depending on who you're talking about, sometimes it could be two different things and sometimes it is the same thing and that's kind of where I think you've seen marketing bleed into what you would call, you know, either CRM or into data to analytics to population health, customer service, patient satisfaction. All those things start to come together. The more you centralize that data source. Janet: 08:27 Although I am confused or concerned at what point does a patient's HIPAA information become a problem? I know you're obviously not looking at individual patient records and you don't have access at that level, but at what point is it reasonable to assume that if I am a patient of a particular hospital and you have this information about me that you have tied together, the fact that I like your Facebook page and I click on these links, is that what you're saying you're able to do? Michael: 08:59 It's a little bit more decoupled than that. So we do deal with a clinical information and patient records and that makes kind of the bulk of a healthcare CRM. So a healthcare CRM is really a combination of the clinical record combined with demographic and socioeconomic information. We use that information to run analytics, to do outbound campaigns, to pull an email list. Michael: 09:21 That's a very simple example when it comes to the Facebook side of things. What we're using is the native Facebook targeting capabilities and then we are using the conversions that we're getting through a target audience that we maybe have identified inside the Facebook and any conversions that happened through that. Whether it's somebody making a phone call, you know, maybe somebody's talking to a call center, somebody filling out a form or registering for an event. That information does make its way into the healthcare CRM database and that can be used for marketing standpoint, in which case none of the PHI has revealed or it can be used from an analytic standpoint in which case you mind into the clinical data to look at things like procedure codes and diagnosis codes and contribution margins and that type of more detailed clinical information. Janet: 10:10 I didn't even realize that this magical ability to combine social data and patient information actually existed. Janet: 10:20 So for instance, with your tool, you can create an advertising campaign on Facebook and say, I want to target prediabetic diabetes patients and I know I need to be including these kinds of demographics. Or is that an oversimplification? Michael: 10:40 Facebook opens up literally thousands of different demographic and socioeconomic targeting attributes directly in Facebook. So that's probably something that anybody who's new to Facebook marketing probably doesn't understand about how Facebook actually makes money. I think most people think about Facebook marketing to in terms of I'm going to go after my fan base, you know, and targeting your fans is what we would call organic social and you have a relationship with your fans and that's a way in which you can communicate to them, I would say kind of the first generation of Facebook. That's kind of what people did, right? That was kind of the standard way to do any type of marketing. Michael: 11:22 There's a lot of limitations to that. Couple ones are your fan base is limited. I'm your fan base is not necessarily made up of people that you want to market to. Especially with the health system. You'll find that a lot of people who are fans of a health systems Facebook page aren't usually patients. A lot of times their friends and family of people who work there, so it's not really a great targeting pool. So then it opens up the rest of kind of Facebook marketing and what people don't usually understand about how Facebook actually makes money and how they sell ad space to marketers is Facebook is buying, you know, millions upon millions of consumer records. So Facebook will partner with folks like Experian data logics, Axiom, Bluekai, who are the same type of consumer companies that you use to do any type of consumer analysis, right? Wherever you could do direct mail or, or whatever. Facebook buys all that data and then they match it to your record inside of Facebook. they do a cross reference and they make all of those hundreds and hundreds of attributes available back to marketers who are doing marketing. And that's how you get access to things like demographic, socioeconomic, income, education, ethnicity, all those types of targeting parameters become available via Facebook, through their acquisition of third-party consumer data. Janet: 12:43 Okay. I have actually purchased ads on behalf of some healthcare clients and we're doing things generally with demography, but more targeting who likes this page, who likes this association, who has an interest in this, a healthcare organization or this health issue. So, because I'm usually with my clients doing B to b business to business tracking. But what you're saying is the hospital could be actually looking for patient profiles in. Michael: 13:18 Yeah and the best analogy for that is healthcare CRM has existed for healthcare for probably the last seven, eight, nine years. Those types of marketing databases, the same type of queries that you would run on those, you can find good substitutes for those just querying directly into Facebook. So that's a real easy way to open up Facebook audiences to be much bigger than just your fan base. You know, Facebook really about four years ago, five years ago, really turned their ecosystem into a pay for play kind of environment where there was not a lot of free marketing left inside of Facebook. You had to go pay, you had to run ads. It was inserting suggested content in newsfeed posts and sponsored stories directly into the newsfeed, was the way in which to actually reach your audience that you wanted to get to. so from a healthcare standpoint, that opens up a couple things. Michael: 14:12 The first thing that opens up is it's the largest audience that you can reach at any given point in time, online period, end of story, right? So if you had to pick one channel, if you are going to focus your dollars on Facebook's going to be the channel that you're going to want to spend those dollars. It's the largest and most engaged audience that you can find online. Certainly in North America. And you can spend $5. Yeah. And it's very cost effective where if you try to compare that to what you might do in Google, so the Google would be the other primary paid channel. Google is also highly effective and most health systems are very familiar with how to do Google ad words into how to use google to identify and capture demand. The thing with healthcare in Google though is that it can be very expensive because medical related keywords and Google can have a pretty high price tag, so highly effective, but it could be less efficient with your marketing dollars because it can be very expensive. Michael: 15:13 Facebook has a wider reach and a more engaged audience, so that was the first part. Second part is that it also opens up mobile where most of the traffic that you're going to see on Facebook is mobile. If you're going to do a mobile first web strategy, you should have a mobile first marketing strategy and for us we think that that's a Facebook strategy. I think the stat is something like one out of every five minutes spent on a mobile device is spent within Facebook, which is just an insane number. Very embarrassing for me to admit that that's true. I get to say I do this for a living, so I have a reason to keep opening Facebook. Exactly, and it cuts across. You know, if you're, if you're going to go mobile, right? If, if, if that's your strategy. The reason why I think it's effective is I think mobile's the one medium that kind of cuts across demographic and socioeconomic boundaries where you know, mobile, you can reach a urban audience in a rural audience, you can reach an older and a younger population. Michael: 16:11 You can reach a affluent and a middleclass and a poor population. Everybody has a smartphone, and this wasn't true five years ago, six years ago, but now the numbers are astounding about where people choose to use their dollars and that first purchase really from a technology standpoint, is to have a smartphone where that, you know, that technology barrier they used to talk about was, you know, there's homes in households that couldn't afford a computer, you know, and that's still true, but they can afford a smartphone and you really capture everybody in that medium and Facebook is the way to do it. So Facebook's the way you're actually going to have the paid channel to go open up that audience on mobile. So that's the other reason. In addition to the targeting capabilities, which I mentioned earlier, when you talk about doing Facebook marketing and advertising, obviously I assume you you're working with the marketing channel, but do you find the clinical side of the house is interested in this data as well? Michael: 17:10 I think the clinical side of the house is more interested in understanding the data, less about the marketing. What I hear when we talk to marketing departments is the difference between the clinical folks, the marketing folks, the population health financial folks. I think the thing that they all have in common is they all want to see some type of results and they want to see some type of measurement. That's where I really like to focus on the data side of it and that's why the CRM side of things is, is pretty interesting. Social for me starts to become kind of that second pillar of a two pronged kind of paid digital strategy and I think everybody is comfortable with using social as a channel just for engagement but also for acquisition and that wasn't always the case when we were doing this kind of five or six years ago. Michael: 17:55 We got a lot of blank stares around how we were going to use that channel. I'm not just for communication but also for for acquisition. I think everybody's really comfortable with that now to the point where they actually expect it and I think the users have come to expect it as well and health systems have caught up to the point where they're very comfortable working in that medium where it was. That wasn't the case three or four or five years ago. Janet: 18:21 What would you say healthcare is still uncomfortable with? Michael: 18:25 That's a good question. I have this discussion a lot with marketing departments in. It's usually the difference between what I call, you know, HIPAA and PHI versus their privacy policy and I think these two things get conflated quite a bit in the healthcare marketing environment where what is usually a limitation of a privacy policy is kinda confused with legal guidelines and recommendations under HIPAA because they're two totally different things. Michael: 18:55 Right? So how you choose to communicate to a patient or prospective patient is usually covered under a privacy policy and what you see for most health systems and a privacy policy are very old, very antiquated privacy policies that were put together by an overly conservative compliance and legal department and those type of rules and restrictions usually have to deal with. If somebody has given me their information online or through the patient portal or through a form or from an inquiry, what am I limited in doing with that information and that has nothing to do with HIPAA. That has to do with the privacy policy and the website says, if you fill out some information here, we're not going to use it for marketing. Well, plenty of health systems have more liberal policies and their privacy policies, which then gives them the ability to do standard type marketing communication such as send me an email, but respect if I opt out, you can communicate to me in many different channels, but respect if I opt out or tune out that message. Michael: 20:03 Those things are applicable and available depending on the privacy policy. All that says is if a patient is providing information, how do you treat that information? Do you keep it secure, then mitigate risk, how do you choose to use that information based on what they've authorized you to use it for? So it's usually two different things and I talked to kind of compliance departments and marketing teams about understanding the difference and what necessarily is legal versus what is allowed under your own guidelines. Janet: 20:39 Okay. So in the Facebook world, and if I am a small business or even a healthcare organization, I have an email list of marketing email list. I can upload the email addresses only, no other information whatsoever. Facebook will try to match them and they'll say, oh, guess what? We found about a third of your patients or customers we have now matched and we've created this magical file that we have tagged who your customers are. We now are going to destroy your email list. We don't keep it, we don't use it, we promise, we promise, and then you, you, you can use that to build your own custom audience. And then you can tell Facebook, okay, now find people who look like my people but who are not my people. Sounds great. But somewhere along the line, because this is patient information, is there an approval process necessary? Michael: 21:34 Yeah. And that again goes back to your privacy policy. So a couple things on the process that you just walked through which is in line with what we've, what we do with some health systems. If their privacy policy and their compliance officers approve it. So a couple things on that. First thing is you never send an email address to Facebook. So that's kind of a misconception is the email just never gets to Facebook. On our own servers, we do what's called a hash encryption and that information is sent to Facebook, so the email address has never sent and the information that you send to Facebook can never be unhappy, so it's completely like a one-way encryption essentially of that information. So because of that, there's absolutely no way to ever have a breach. Would that information and the HIPAA and privacy guidelines, the intent of them is to mitigate risks, risk to make sure that you don't have some type of inexperience or an Equifax breach and there's absolutely no way in the protocol that's used to send that information to Facebook that you could ever have a breach. Michael: 22:35 So that's the first thing. The second thing is when they do identify those people, they never tell you what people are actually identified. So if you send a thousand people that's been hashed information, Facebook, they matched 700 of them. You never actually know which 700 and neither does Facebook. So it sits in a way in which it's a one-way mapping which can never be downloaded or breached or have any type of intelligence about who that person is. So that scenario, we've worked with many kinds of compliance departments and legal folks at health systems and that's usually sufficient once you walk through that and explain to them how it works, they're cool. In fact, what I find, what happens more often is people use the same email addresses and they're sending them to Mailchimp or constant contact or other far less secure places than sending it to Facebook. Janet: 23:28 Okay. I'm glad you said all of that because that was obviously the one disconnect that I needed to have clarified and that little five minutes is now going to be the piece I share with everyone because I have talked to lawyers about it and they do fall back to the privacy policy, but for most part they're not really aware of the ins and outs of how data a gets to a location b. all right. So I feel really good about that. So I'm going to encourage a lot of people to consider doing that. but tell me about where you want to take all this fascinating data and intelligence. Are you doing anything with data visualization and, and looking at a bigger picture about trends about how people are, are using a Facebook and, and is that actually triggering visits to a healthcare provider? Michael: 24:20 Yeah. So I think as it relates specifically to Facebook, I'm a couple of years ago when I would talk about Facebook, I kind of changed how we frame Facebook. So it used to be kind of framed as hey are you doing social media marketing? And then a couple of years ago I kinda changed our approach and that kind of stopped calling it social media marketing and just lumped it in with digital marketing because it's less about the social side of it and more about this is just the dominant place to reach people online. And the fact that it happens to be social in nature is kind of besides the point now where, you know, Facebook is. I mean it hasn't gone anywhere. It's been around for over 10 years, continues to grow their numbers, look, continue to look strong. Their revenue numbers are strong. Michael: 25:09 Other competition that comes up like an Instagram, they buy Instagram, Snapchat comes up and they just replicate all of Snapchat's features. So they buy Whatsapp, you know, they create messenger so they're kind of here to stay. So it's Kinda like, you know, rather than saying, do, do you do search marketing? It's like it's google, you know, google is kind of like Google one, right? Facebook kind of one this side of it. And when it comes to digital ad spend, there's two dominant players. It's Google and then Facebook and everybody else behind that are niche players at best when it comes to the ad dollars that they consume. So it's really less than it being social because there's lots of cool social things about it. And almost anything you do online today has some type of a social component, right? Is plugged into some type of a social graph. Michael: 26:07 It has some type of engagement or commentary or some network effects in place. So everything's kind of social. So treating Facebook as a social media marketing I think is kind of besides the point, and I think of it as I have a limited number of channels that I can go out to with my limited marketing dollars because we deal with health systems and in the grand scheme of things, health system is still kind of a small business when it comes to the amount of marketing dollars that they spend. You know it's not IBM. It's not Coca-Cola, you know they don't. They don't have a ton of money and so you have to be really careful about what channels you use because your marketing dollars are limited and you want to make sure that they're going to the most efficient channels. And to me, the top two are going to be Google and Facebook and everything else. You have to make a really strong case to want to spend money in those channels after you've saturated Google and Facebook. Janet: 27:02 When you work with clients, you're coming in because you have a lot of answers and capabilities in the digital space and the online space. But the way I hear you're talking, I'm hearing that while there shouldn't be social media marketing or digital marketing, now I'm wondering is, is it all just marketing now and at what point are we going to stop having a digital online budget and a traditional budget and it's all just one budget? Michael: 27:31 That's exactly the way people should be thinking about it. And I think what I've learned from doing this over the last six or seven years is people used to ask, you know, they would say, well, what channel is better or what's better should I use this or that? And what I've learned is, you know, it depends, you know, different service lines have different calls to action, different, goals. And you know, running an orthopedic campaign is a lot different than running a pediatrics campaign or a breast cancer awareness campaign. You know, we're running a bariatric surgery, campaign and all those things have different nuances about who's the audience, how do you want to engage them, where do they respond, what are the costs in the individual channels that you could use? And I think they're all kind of different and you do them enough and you start to figure out that there's a different combination that works and all those combinations of channels and budget levels are really just kind of starting points and then you figure out what's working in that individual market for that specific health system and then you go from there. Michael: 28:34 So I think that's a long way of saying, yeah, it should be treated as all one budget and then you figure out what's my most efficient allocation that are the channels that are going to drive the best results. And then you go from there. I don't think it's one hard fast rule about what you should use or shouldn't use, let alone do I carve out different budgets for your digital versus offline. I think it should all be looked at together and then you make a decision based on what you believe is gonna be the most efficient allocation. Janet: 29:02 Now one of the things I'm hearing from you is really an evangelism for understanding the holistic role of marketing and of digital in the whole. And I understand that in the sense you are a thought leader and you're going out to share this evangelism, you're really on a speaking tour, are hitting a lot of conferences. So where are you going to be going in the next few months to tell people about, these new ideas. Michael: 29:31 Thanks for mentioning that. I try to stay engaged with the healthcare marketing community as best I can. We were at SHSMD a couple of weeks ago and coming up here October 23rd through the 25th is going to be HCIC healthcare Internet conference that's going to be an Austin, Texas and I'll be doing a panel discussion there, which I'm really looking forward to. It's going to be on the role of healthcare CRM and what does that mean moving forward. And like I was saying before, you know, CRM is a big piece of what I've been working on recently and marketing is a huge component to a, to a CRM system. So if anybody is going to be in Austin, Texas, October 23rd to 24th will be at the HCIC, a healthcare Internet conference that center since it's, since we brought it up that they actually, the health care conference I think has always been the best, for the customers and for the industries and the products that I work with lately. Michael: 30:34 I think it's always the right mix of people. It's not too big. It's not too small. Always has a pretty good sense of what is trying to accomplish. The speakers are usually pretty good at the conference is not too long and again, it's not too short. so hci is coming up and then also in 2018 I will be speaking at HIMSS this year and looking forward to that hymns. For anybody who's not aware is enough. That's going to be March fifth through March ninth in Las Vegas and I'll be doing a speaking session there with Christus health. Christus health is a health system in Texas, actually much larger than that, but their headquarters in Texas. And we're going to be talking about how to leverage healthcare CRM beyond marketing and since we're talking primarily about kind of social and social media marketing on this call today on this podcast, I really start to see marketing bleed into a lot of different areas and marketing I think has got a lot of attention over the last five years in healthcare, but I think they're taking on more and more responsibilities and various departments are starting to kind of bleed together. Michael: 31:50 Is it a patient satisfaction? Is it customer service? Is it population health? All of these things start to converge and marketing's, they're converging with it as, as well. with how do you actually manage a patient population? How do I communicate with the community? How do I know more about my healthcare consumers so that I can better not just better market to them, but then how can I better engage with them once they come in to the health system. And that's something that healthcare, particularly the healthcare providers are learning how to do. And as compared to other industries, they're really not very good at it, you know, and they're, they're getting a lot better. Janet: 32:26 Well, let me ask you to put your prognosticators hat on and as you are a little bit on cutting edge here, when we talk about CRM and things happening in the digital space, what you see as big changes coming down the pike, either that we can avoid the, might as well embrace it or that really could be game changers from a standpoint of healthcare marketing and slash or social media. Michael: 32:52 Let me touch on the last point there first. So as it relates to healthcare and social media, first of all, Facebook isn't going anywhere. I think after four years or five years of Facebook, people are like, oh, is this a fad? Is this going to be my space? Or something like that. Nope. Facebook one, it's dominant. It's a platform for the next 15 to 20 years. Easily. Facebook is not going anywhere. Twitter's kind of a dud when it comes to marketing. So I was really positive on Twitter about two or three years ago and have not seen any of the campaigns that we've run in Twitter, provide a meaningful challenge to what we're seeing in Facebook or google. So I think Twitter is kind of missed the boat when it comes to a paid marketing channel. Like I said before, Instagram is part of Facebook and I see a lot of great things in Instagram. Michael: 33:43 So Facebook makes it pretty easy to extend your marketing campaigns into Instagram now. So I think that's big. Snapchat I think is you're kind of number three player in the social space. I dunno if it's great for health systems yet they haven't really figured out how to turn it into a direct response or a conversion channel. It's more for brands, you know. So it's getting big branding dollars from national and international advertisers don't see it being a big channel for, for health systems yet. I'm one of the channels I'm more interested in from a marketing side is actually next door. So I don't know if any of the listeners have used next door. Next door is a neighborhood social network and as far as an ideal audience for health systems, I think next door could be really interesting, so that's something to be on the lookout for. Janet: 34:33 I actually joined my organization that I've been living in my neighborhood for 15 years and next door has been around actually for quite a while, but I finally bit the bullet and joined I know six or eight months ago and I now actually no my neighbors all days. You take cookies next door you'd meet, people know everybody stays inside, but I feel like I know them virtually through next door and the amount of recommendations and or questions for services is amazing. Plus people give away a lot of great free stuff. Michael: 35:06 Yup, Yup. It's highly trusted. They're starting to open up from a marketing standpoint, I think it's to be determined how health systems could use it, but it seems a natural fit for community interaction for a health system, for a physician practice, for an urgent care to be nearby. Highly, highly relevant. I think for healthcare, I don't know if it's going to pay dividends from a marketing standpoint, but I would keep my eye on that. When it comes to kind of new and innovative things to look out for kind of coming up in the kind of the healthcare or the marketing technology space, I've had this question a lot and it's not a really sexy, interesting answer. It's really actually kind of boring if I think it's things like call center. So the front lines of patient communication is who answers the phone when somebody responds to a marketing campaign, it's kind of an overlooked but really critical thing that health systems do really poorly and as they get marketing sorted out, whether it's search or social or digital or offline or email or direct mail, they're getting those things figured out and they have their own problems and that's getting sorted out. But the problem that persists is, hey, that's great. You did a great marketing campaign. What happens when the person signs up for something or when they make a phone call? It's a highly broken process from an operational standpoint, which requires a lot of technology to integrate to things like scheduling a two callbacks to follow-ups and that all connects directly to marketing if you ever want to figure out what's happening. Michael: 36:45 So it's not a very interesting kind of, you know, high tech answer. It's kind of fixed the call center. Janet: 36:50 Well, and that's the challenge, right? Nobody wants to work on the boring everyday stuff. They all work on the sexy new things, but I understand your title is a Senior VP and GM of Consumer Experience. That's unique. Yeah, and I think you're going to see that trend a lot. Even in health marketing. Our marketing teams are moving away from the marketing term and it's kind of becoming more a patient experience. Consumer experience. When I talk and when I do, I'm a collateral or presentations. I tend to downplay words like patient because I think in healthcare now I think patient implies somebody's sick and so much of what we're doing is about wellness and preventative and being involved and taking care of your health and if you're taking care of your health, I don't think you're a patient. Michael: 37:40 Right. And then things when it comes to, you know, terms like acquisition rather than acquisition, things like experience where the health system is now trying to engage with the community to be able to influence the healthcare decisions that they're making. And that crosses a wide gamut of is it preventative, is it wellness, is it child care, is it pediatricians or is what we normally think of kind of acute care, right? I'm hurt, I'm sick, I need to go to the doctor. So I think you're seeing a lot of terminology change there and that's happening because health systems are, are growing in their responsibilities and also that's why you see marketing kind of bleeding into other groups and it's becoming more about consumer healthcare, consumer experience rather than particularly how do we treat or find sick patients? Janet: 38:31 Well, everything you're saying is so exciting because it sounds, if not easy, doable. Speaker 3: 38:38 Yeah. I think a lot of this stuff is pretty like I said, I think marketing's been getting better. it's come light years in the last four or five years. I think now they're struggling with data and making sense of the data because there's a lot of data from a lot of different disparate systems within the health system and then how do I actually close that middle layer? Some of it is kind of basic blocking and tackling and it's kind of the boring stuff sometimes. But you know, a lot of successful companies, a lot of successful people got that way by solving kind of the boring problems, ones that no one else wants to tackle. Janet: 39:14 Exactly. And make them seem fun on the front end because they weren't focused on user experience. Michael: 39:20 If you had asked me 20 years ago if I was going to be doing healthcare marketing and talking about a healthcare call center, I would've told you you're crazy, but there's a lot of stuff that you can do there. And I think it's a hugely kind of overlooked, a niche in the industry and I've been happy to be a part of it over the last six or seven years. Well, that is exciting and I look forward to reading your posts and social and following your talks at coming up events. I think you've got a really great solution and I expect even better things coming from you all in 2018 and forward. Michael: 39:51 Well, thanks again, Janet. I appreciate it. Thank you so much for being here. No problem. Talk to you soon. Announcer: 39:57 And now here's our social media success tip. Jeff Callaway: 40:01 Hi, this is Jeff Callaway. I'm the Senior Content Specialist at Cook Children's Healthcare system based in Fort Worth, Texas. My advice would be to not be too PR, which sounds weird because I work in PR and I know a lot of you listening do as well, but we try very hard to write as journalistic as possible to make the stories interesting and to make what we do appointment viewing and to create a trust with our audience that when they read it, it's going to be real and accurate journalism. Announcer: 40:34 You've been listening to the Get Social Health podcast. The show notes are located@getsocialhealth.com To join our healthcare social media journey, follow at, Get Social Health on Twitter and start a conversation. Janet: 40:50 Thanks for listening to the Get Social Health podcast, a production of the healthcare marketing network, and a proud member of the healthcare podcasters community. Janet: 40:58 I like to take a moment to tell you a bit about the healthcare marketing network. We're a community of freelance healthcare writers. Our Organization can match your company or a healthcare practice with clinically accurate, specialized or general health care and medical content from blogs to white papers to Cmi. The healthcare marketing network has the writers that you need to reach your business audience or patients to find out more, visit healthcare marketing network.com, or contact me via social media, or you can email me, Janet@healthcaremarketingnetwork.com. Thanks again for listening to the Get Social Health podcast.
In this week’s special bonus episode, we had the honor of speaking with Professor Craig Garthwaite, Associate Professor of Strategy and the Director of Healthcare at Kellogg. Professor Garthwaite is an applied microeconomist whose research examines the effects of government policies and social phenomena with a focus on the health and biopharmaceutical sectors. His recent work has focused on the private sector effects of the Affordable Care Act, including the labor supply effects of large insurance expansions, the changes in uncompensated hospital care resulting from public insurance expansions, and the responses of non-profit hospitals to financial shocks. In prior work, he has examined the impact of government cash assistance programs on health and the effect of changes in expected mortality from the emergence of crack-cocaine markets on educational attainment. Professor Garthwaite has testified before the United States House of Representatives and several state legislatures on matters related to the minimum wage and health care reforms. Professor Garthwaite also studies questions of pricing and innovation in the biopharmaceutical sector. In this area, he has examined the effect of expanded patent protection on pricing in the Indian pharmaceutical market, the innovation response of United States pharmaceutical firms to increases in demand, and the relationship between health insurance expansions and high drug prices. His research has appeared in journals such as the Quarterly Journal of Economics, the American Economic Review, the Review of Economics and Statistics and Health Affairs, and you have likely seen his work and interviews in the Wall Street Journal, the Washington Post, and Vox. He has also appeared as a guest on various television and radio shows such as Nightly Business Report and NPR Marketplace. In 2015, Professor Garthwaite was named one of Poet and Quants 40 Best under 40 Business School Professors. A few of the topics that Chuck and Professor Garthwaite cover in the episode include: Professor Garthwaite’s background and how he arrived at his position at Kellogg The causes behind why we are seeing a recent trend in vertical integration among players in the healthcare space The incentive alignments between mergers such as CVS and Aetna and what the lay consumer might not understand about the benefits of such a merger Professor Garthwaite’s thoughts around what can be done about the high drug prices in the US Professor Garthwaite’s perspective on the Amazon- Berkshire-JPMorgan health venture and ideas around what these 3 companies aiming to achieve together Many point to misaligned physician incentives or the increase in diabetes or people not leading healthy lifestyles, that lead to the high healthcare costs in the US but Professor Garthwaite shares other factors to consider in this debate as well The tradeoff between innovation and access to care and how Professor Garthwaite defines innovation The type of “disruption in healthcare” Professor Garthwaite thinks truly has merit and will have impact Professor Garthwaite’s current research on Hospitals as Insurers of Last Resort and how hospitals may not be passing along all uncompensated-care costs to other parties such as hospital employees or privately insured patients Connect with Professor Garthwaite: Kellogg Profile Professor Garthwaite on Twitter LinkedIn Healthcare at Kellogg Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
This week’s bonus interview welcomes Lee Shapiro of 7Wire Ventures to the podcast. Lee is Managing Partner at 7wire Ventures, an investment firm he co-founded over a decade ago. The fund’s focus is on building companies that empower connected informed health consumers to improved outcomes, facilitating the change from sick-care to wellcare. He is active with the 7wire portfolio and the boards of Livongo Health, Ayogo Health, Carebox, Zest Health, ConsejoSano, Modern Teacher and Education Funding Partners. He also serves on the boards of Medidata Solutions [NASDAQ:MDSO], Tivity Health [NASDAQ:TVTY], and Aptus Health (a Merck subsidiary [NYSE:MRK]). As President of Allscripts [NASDAQ:MDRX] from 2001 through 2012, his leadership was central to over $4B in mergers, acquisitions and financings. He oversaw the company's strategy, international operations, business development and partnerships, health plan initiatives and entrepreneurial business investments. He is a member of The World Innovation Network Board (TWIN, formerly known as Northwestern Kellogg KIN), the University of Chicago Innovation Fund Advisory Committee, The Samsung Strategic Advisory Board, The Qualcomm Life Advisory Council and the advisory board for the Center of Digital Innovation in Digital Health in Beer-Sheva, Israel. Lee is a member of the National Board of Directors of The American Heart Association and has served as an officer and director of the Gastro-Intestinal Research. Also joining this episode was special guest, and Healthbox President, Neil Patel. In this Episode, Chuck, Neil, and Lee discuss: Lee’s early career, how he became President of AllScripts and some of the biggest lessons he learned at Allscripts How Lee realized and arrived at the investment thesis for 7Wire Ventures? Lee’s vision in creating, essentially, a 2-sided market, with startups on one side and 7wire’s strategic LPs on the other, which includes such names as Horizon Blue Cross Blue Shield, Memorial Hermann, and Rush University Medical Center, to name a few. With such a diverse set of strategic LPs, Lee’s philosophy on how to engage them in the investment process and in portfolio support Lee’s thoughts around innovation in Chronic care management and if, due to the recent emergence of advanced IOT and AI, we are on the cusp of seeing some major changes in this area What gave Lee the conviction early on to invest in a crowded disease management space, having participated in many of Livongo’s early funding rounds Lee’s approach to looking for and identifying new innovative healthcare business models and how the firm proactively looks to foster these types of models What Lee thinks is special about having his firm based here in the Midwest Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn Connect with Lee: 7Wire Ventures 7Wire Twitter LinkedIn
This week’s episode welcomes Erik Pupo, managing director in the Accenture Health Client Service Group, for the final part in our series around Blockchain Innovation in Healthcare. Erik is Accenture’s Healthcare Blockchain lead for North America, where he leads sales and implementation efforts with Accenture’s payer, provider, and life science customers on how to use blockchain technology to improve efficiencies within their businesses. Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. A speaker and thought-leader on trends influencing the healthcare industry, Eric holds leadership advisory positions within the American Health Information Management Association, the Healthcare Information and Management Systems Society, where he also became a fellow in 2012, and the Healthcare Financial Management Association. Previously, he worked at Deloitte where he led several health IT initiatives for the Office of the National Coordinator for Health IT, the Department of Defense, and the Department of Veteran Affairs (VA). In this Episode, Chuck and Erik cover: Erik’s background and how he became interested in the blockchain Erik’s team and his role inside Accenture and the types of projects and thought leadership they produce How one “builds a blockchain” Who can actually touch or use the blockchain in a practical sense If different blockchains are interoperable with one another or can they be adjusted to be Blockchain innovation in the pharmaceutical industry How the blockchain can be used to help underserved populations and rural communities Erik’s advice to entrepreneurs building technology in the Blockchain space and to healthcare organizations who want to implement Blockchain technology Connect with Erik: Accenture Twitter LinkedIn Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Our guest today, John Bass, joins the podcast to talk about the use of the blockchain in healthcare and how it will drive innovation, now, and in the future. John is CEO of Hashed Health, a healthcare blockchain innovation firm focused on building the new digital infrastructure for healthcare. John has over 20 years of experience in healthcare technology with expertise in shared operating systems that build trust, transparency, and incentives across health networks. Prior to Hashed Health, John was CEO at InVivoLink, a care management start-up which sold to HCA in 2015. Since then, John has been a leading voice in the development of the global healthcare blockchain market and is focused on community development, enterprise services, and blockchain solutions development. Topics we cover in this episode: John’s background and focus on improving patient outcomes When the blockchain actually came to be and when and why it piqued John’s interest What the blockchain is The types of problems using the blockchain in healthcare aims to solve and how Hashed Health aims to accelerate this process How the blockchain will truly be disruptive in healthcare Connect with John: LinkedIn Twitter Connect with Hashed Health: Website Twitter Resources https://chat.hashedhealth.com https://hashedhealth.com/blockchain-healthcare-resources/ Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Our guest today, Anand Parikh, General Counsel and Head of Business Development at Virta Health, joins the podcast for the first part in our series on Innovation in Chronic Disease Management. Anand began his career as Senate Fellow for the California State Senate and a clerk for the United States District Court. He then practiced at Morrison & Foerster LLP before joining Virta in 2015 as the company’s Chief of Staff, and 5th employee, and moving into his current role in 2016. Virta is a treatment that safely and sustainably reverses type 2 diabetes without medications or surgery. Virta achieves this through innovations in nutritional biochemistry, data science, and digital tools combined with clinical expertise to shift the diabetes treatment paradigm from management to reversal. The company’s mission is to reverse type 2 diabetes in 100 million people by 2025 and they have some exciting clinical evidence and proven patient results to support that goal. In this episode, we cover: Anand's background and his career and what led him to Virta The evidence that existed behind what Virta was trying to achieve when he joined the company The story of how the company came to be, how it was founded, and where the original business model came from Anand’s main responsibilities as General Counsel and Head of Business Development How the Virta Health model works from a diet and coaching perspective How Virta's technology platform has evolved over time How Virta leverages the data collected to iterate on the platform How Virta has taken something like diabetes treatment, which is inherently a high-touch and personal, and added a technology layer while ensuring not only patient buy-in but compliance The uses of behavioral economics Virta Health employs to drive patient change Anand tells us about the exciting results of Virta Health’s recent 1 Year Clinical trial The main goals of Virta’s recent fundraise Connect with Anand: Virta Health Twitter LinkedIn Connect with Virta Website Twitter Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Happy new year from the Healthbox and the Podcast team! We are working hard on some great new series coming up in 2018 but before releasing those, we sat down with Healthbox President Neil Patel to hear about what he’s seeing in the healthcare innovation space and what he is predicting for 2018. In this episode, Chuck and Neil cover: New podcasts series that will be coming early this year, including Non-emergent medical transportation The use of the Blockchain in healthcare Innovation in Chronic care disease management A discussion around innovation and regulation from a government standpoint, including the FDA’s 2018 roadmap, which includes: Four strategic policy areas: addiction crises, innovation, consumer empowerment and the FDA workforce Reduce the burden of addiction crises that are threatening American families Leverage innovation and competition to improve healthcare, broaden access, and advance public health goals Empower consumers to make better and more informed decisions about their diets and health; and expand the opportunities to use nutrition to reduce morbidity and mortality from disease Strengthen FDA’s scientific workforce and its tools for efficient risk management What Neil is most excited about for healthcare innovation in 2018 Connect with Healthbox: Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Today’s guest, Jason Calacanis, joins host Chuck Feerick to talk about his new book “Angel”, what it takes to be a successful angel investor, and a variety of other topics. Jason is a technology entrepreneur, angel investor, and the host of two very popular podcasts, This Week in Startups and Angel. He got his start in the world of startups in New York and his second company, Weblogs inc., was sold to AOL in 2005, after which Jason became a “scout” for top-tier Silicon Valley venture capital firm Sequoia Capital. Since then, Jason has gone on to launch numerous ventures and is currently the founder of a series of conferences that bring entrepreneurs together with potential investors, frequently appears in the media, and most notably is a successful angel investor in over 100 companies, including both Thumbtack and Uber. In this episode, Chuck and Jason discuss: Jason’s earliest role in New York with Silicon Alley reporter and what he learned about entrepreneurship in that process Jason’s first angel investment Why Jason decided to write a book, why now, and why he wants to give away all his best practices and secrets Where Jason says it is most important to be located geographically to be a great angel investor When meeting with a founder, what Jason believes are the most important things an aspiring angel should ask What Jason feels is the best way that angel investors can be helpful to their portfolio companies If Jason thinks that angel investors should stick to investing in the industries they know (e.g. should a doctor only invest in healthcare)? Regarding startup crowdfunding platforms, whether or not Jason feels these platforms are the best place for an angel investor to start and if some are better or safer than others What Jason thinks about ICOs What book, besides Angel, Jason thinks everyone should read Which of Jason’s investments he is most excited about right now Connect with Jason: Twitter This Week in Startups Angel Podcast LAUNCH Festival LAUNCH Incubator Buy Jason’s book, Angel or on Amazon Jason's Private Syndicate Connect with Healthbox: Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
This week’s episode is a special bonus episode recorded live at the 2017 Healthbox Fall Forum with three fantastic guests. The theme of the Fall Forum was Innovating Behavioral Change in Healthcare and each of our guests reflected on their biggest takeaways of the Forum and what they can do at their organizations with the knowledge they gained. Featured in this episode are: Desert Horse-Grant, Senior Director, Research and Innovation at UCLA Health LinkedIn UCLA Health Alec Zopf, CTO of Wellth LinkedIn Twitter Wellth David Hochheiser, SVP Provider Networks & Healthcare Value at BCBS Louisiana LinkedIn BCBS Louisiana
Our guest today, Dr. Sam Volchenboum, is the Associate Professor of Pediatrics, Associate Chief Research Informatics Officer, and Director, Center for Research Informatics at University of Chicago Medicine. Dr. Volchenboum is an expert in pediatric cancers and blood disorders. He has a special interest in treating children with neuroblastoma, a tumor of the sympathetic nervous system. In addition to caring for patients, Dr. Volchenboum studies ways to harness computers to enable research and foster innovation using large data sets. He directs the development of the International Neuroblastoma Risk Group Database project, which connects international patient data with external information such as genomic data and tissue availability. The Center he runs provides computational support for the Biological Sciences Division at the University of Chicago, including high-performance computing, applications development, bioinformatics, and access to the clinical research data warehouse. He is also currently collaborating with Google to use machine learning for better health care and has been written about in both Wired.com and the Washington Post. If all that wasn’t enough, Dr. Volchenboum is also co-founder of Litmus Health, a data science platform for early-stage clinical trials. In this Episode, Chuck, new Healthbox team member and guest host Jessica, and Dr. Volchenboum discuss: Why Dr. Volchenboum chose to earn a Master’s in Biomedical Informatics from MIT and Harvard Medical School and how he merged that with his passion for computer science What the old way predictive modeling looked like and how data was made actionable, before the use of current applications of artificial intelligence What the U Chicago Medicine’s Center for Healthcare Delivery Science and Innovation is focused on and some of the biggest problems Dr. Volchenboum and his team are working to solve How Dr. Volchenboum’s collaboration with Google came to be, the big problems being tackled, and which of Google’s tools are being used As co-founder of Litmus Health, Dr. Volchenboum talks about the company and what spurred him to make the entrepreneurship leap What’s next for both Dr. Volchenboum’s Google collaboration and at Litmus Health Connect with Dr. Volchenboum and his work: LinkedIn U Chicago Profile UChicago Medicine collaborates with Google to use machine learning for better health care UChicago Medicine and Google — a data-driven duo to watch Data Commons to Support Pediatric Cancer Research Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs Blog post Litmus Health Connect with Healthbox: Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Our guest today, Elad Benjamin, joins the podcast from Israel for the second episode in our series on innovation and the use of AI in healthcare. Elad is CEO and Co-Founder of Zebra Medical Vision and is a veteran Healthcare IT executive with over 20 years of experience in software and medical devices, in both startups and Fortune 500 companies. He has held senior roles in Healthcare IT companies, including playing key roles in taking companies public on the NASDAQ as well as managing complex global businesses implementing solutions in medical providers worldwide. Elad holds a BsC from Tel Aviv University and earned his MBA from the Stanford Graduate School of Business. In 2014, Elad co-founded Zebra Medical Vision, an automated medical imaging diagnostic engine featuring a vast database and using machine learning to create diagnostic insights that will help physicians be more effective in treating their patients. To date, Zebra Medical Vision has raised over $20 million in venture funding from top tier firms including Khosla ventures, SalesForce co-founder Marc Benihoff, and Intermountain Healthcare. In this episode, Chuck and Elad discuss: Elad’s background and how he initially got into healthcare and healthcare technology Where the idea for Zebra Medical Vision came from The biggest lessons Elad has learned from running his first company to now being at the helm of Zebra Medical How Zebra Medical ensures the AI within the platform only learns from the best data and gets smarter over time while staying uncorrupted How fast Elad believes the use of AI is moving in healthcare and how far he thinks we are from something truly industry/world changing How Elad earned investments from some of the world’s most well known venture capital firms The importance of the makeup of the Zebra Medical Board and what Elad looks for from a board member with such a technical business Connect with Elad: LinkedIn Twitter Connect with Zebra Medical Vision: Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Our guest today, Kevin Freedman, joins me to talk about innovation and the use of AI in healthcare. Kevin is founder of NextPhase Partners, a firm providing independent support and guidance to entrepreneurs as they guide their companies through their next phases of growth. Prior to NextPhase, Kevin was an operating partner at Khosla Ventures and has more than 15 years of operating experience with leadership roles in both consumer and enterprise technology companies. Before joining Khosla Ventures, Kevin was the CEO of Quid, a leading SaaS business intelligence platform, which Fortune 500 companies from Intel and McKinsey to Samsung and Barclays, among others, utilize to better understand the web’s unstructured data. Prior to Quid, he was an early executive at Slide, and took on the role of CFO where he built out the company’s business functions as they scaled to 150 million monthly users and ultimately drove the acquisition by Google. Earlier in his career, Kevin held a variety of senior operating roles at eBay and PayPal, with his initial success in Silicon Valley beginning with Half.com, which was acquired by eBay in 2000. In this episode, Chuck and Kevin discuss: Kevin’s background, and the path that led him into the world of startups and venture capital What are the roles and responsibilities of an “operating partner” How the investment in Zebra Medical Vision came to be and what got Kevin interested in taking a board seat The impact that Kevin thinks AI will play in Healthcare moving forward Connect with Kevin LinkedIn Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
This week’s bonus episode was recorded live at the 2017 Healthbox Studio Showcase! Healthbox hosts the program to support and advance entrepreneurial innovation, which aligns with our overall mission to empower the reinvention of healthcare. The program helps accelerate emerging digital health companies and fosters relationships between startup founders and industry leaders. Healthbox hosts the program free of charge to selected companies with no required equity exchange. The Studio ran from October 9-13 at the Healthbox office in Chicago, IL and featured presentations, workshops, and mentor sessions from the Healthbox team and other industry leaders. In this episode, host Chuck Feerick sat down with four participants from the Studio to explore what their companies do and the problems they solve, what some of their biggest takeaways from the week were, a favorite session or two from the week, and what is the first thing they’ll do once they get back to their teams Our guests included: Chris Wyatt, VP of Strategy and Sales at Parasail Health Parasail Health helps providers and patients focus on treatment instead of payment by offering a suite of products that make medical bills affordable for patients and get providers paid right away. Follow Parasail Health on Twitter @ParasailHealth Matt Pierce, Co-Founder and CEO at TrustedHealth Trusted Health is on a mission to improve access to care by optimizing the healthcare workforce. Their automated matching platform connects the right candidates with the right opportunities better and faster than ever before, starting with America's most trusted profession, nurses. Follow TrustedHealth on Twitter @Trustednurses Andrew Trees, Co-Founder and CEO at Agathos: Agathos is a mobile analytics platform that empowers physicians to optimize their practice patterns and demonstrate the value of the care they provide. Follow Agathos on Twitter @AgathosHealth Bora Chang, Co-Founder & CEO at Kela Health KelaHealth predicts risk for surgical complications using machine learning & proactively intervenes by guiding surgeons on best-practices at the point-of-care to decrease complications and improve quality of care. Follow Kela Health on Twitter @KelaHealth Connect with Healthbox Follow us on Twitter and @Chuckfeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
Our guest today, Drew Schiller, Co-Founder & CEO at Validic, joins Chuck on the Podcast for the final episode in our series around interoperability in Healthcare. Validic is a technology platform for convenient, easy access to digital health data from best-in-class clinical and remote-monitoring devices, sensors, fitness equipment, wearables and patient wellness applications. Prior to co-founding Validic, Drew founded and ran a web development firm, founded and exited a niche dietary nutrition website for patients with celiac disease, and served as an Adjunct Instructor at the University of Iowa teaching graduate courses in web development and usability. Drew is currently a Board Member of the Consumer Technology Association (CTA) Health & Fitness Technology Division and serves on the Leadership Council for the eHealth Initiative (eHI) and participate in the eHI Interoperability Workgroup. On top of that, he is also an advisor for the Clinical Trials Transformation Institute Mobile Devices Project to advance the use of mobile devices in clinical trials. In this episode, Chuck and Drew discuss: Drew’s background, and the path that led him to start Validic How the Validic platform works and helps solves interoperability issues in healthcare How Validic works with partner companies to ensure the data is secure and HIPAA compliant Validic’s recent developments with Microsoft and how Microsoft HealthVault Insights is integrating Validic into its platform Connect with Drew LinkedIn Twitter Connect with Validic: Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
On this week’s episode, we welcome Leland Brewster back on the program for the second part of our series around interoperability in healthcare! Leland is the Director of Fund Management for Healthbox and supports Intermountain Innovation Fund-related activities and heads Healthbox's seed investments in addition to supporting portfolio management efforts across all of its investment vehicles. Prior to joining Healthbox, Leland worked for Clarion Healthcare, a boutique life sciences consultancy in Boston. At Clarion, he was involved in multiple product commercialization and launch readiness projects, as well as the design and launch of a one-of-a-kind patient and physician support program. Leland received his BA in Economics and Chemistry from Williams College and received his MBA from Chicago Booth. In this episode, Chuck and Leland discuss: The Intermountain Innovation Fund and the areas the fund is interested in investing What the evolution of the thesis of the fund has looked like and what led to that progression How the Intermountain fund differentiates from other strategic hospital funds and how they work with other strategic hospital funds How the relationship between Redox and Healthbox came to be and how that evolved into an investment How Leland looks at the current state of interoperability How Intermountain became interested in making an investment in Redox What about Redox and the team made Leland say “yes” Connect with Leland LinkedIn Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review on Apple Podcasts Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on Apple Podcasts, SoundCloud, or Libsyn
This week’s episode is the first part of our new podcast series around Interoperability. Joining host Chuck Feerick on the program is Niko Skievaski, the Co-founder and President of Redox. Based in Madison Wisconsin, Niko started Redox in 2014 to reduce barriers to entry in healthcare technology and has thus created a Modern API for EHR integration. Niko is a board member and co-founder of 100State, Wisconsin’s largest co-working space as well as co-founding BreadcrumbsQA, a searchable Q&A knowledge management platform originally deployed at Epic. In this episode, Chuck and Niko cover: Niko’s background and the path that led him to start Redox The problem Redox solves, how Redox works, and why a solution like Redox is so important Redox’s partnership with CloudMine and what the partnership looks like, as well as other partnerships What the current state of the interoperability market looks like today and what sets Redox apart The interplay between FHIR and the APIs the government promised in the 21st Century Cures Act, as well as the new marketplaces from companies such as Athena, Cerner, and Epic What Niko says has been the hardest part about building the company What the fundraising process was like for Redox and how Niko helped investors understand the magnitude and ROI on this problem Why Niko and team decided to found the company in Madison, Wisconsin and how Madison is in terms of its startup community and resources Connect with Niko LinkedIn Twitter Connect with Redox Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week we have a bonus episode of the podcast with Jeff Hyman, Founder and Chief Talent Officer of Strong Suit, a firm that helps build Rockstar top-teams for VC & PE portfolio companies. In addition to founding Strong Suit, Jeff is an Adjunct Professor at the Kellogg School of Management, is the Author of The Ultimate Guide to Hiring Growth Rockstars and the Host of the iTunes rated 5-star Strong Suit Podcast, and is CEO-in-Residence at Sterling Partners, a $6B Chicago PE firm. Along the way to founding Strong Suit, Jeff has raised $55M in venture capital, and has been CEO and Founder of 4 different companies, including Chicago-based Retrofit, where he is now Chairman. Jeff joins us on the program today to talk about Finding and Hiring Rockstars at your Startup and how to avoid costly mistakes in this crucial process. Topics we discuss in this episode include: Jeff’s background and what led him to building a company in the healthcare space The astonishing number of times Jeff got rejected before one the world's most prominent investors said “yes” to him How Jeff defines a “rockstar”? How a busy founder can build in more time to focus on recruiting How to balance hiring for talent vs. culture and, How Jeff ensures he hires for diversity among teams The best questions to ask during the actual interview Links and Resources: The Strong Suit 8 Immutable Truths of Talent for VC & PE Companies. 1. People are the ultimate competitive differentiation Creating a culture that draws in talent is the only way to stay ahead for the long term. 2. There is no such thing as a perfect candidate You’ll be waiting forever. Instead, identify the must-have competencies & never settle. 3. Recruiting is sales & marketing, not human resources It’s all about the funnel. First, plug the leaks. Then, fill the funnel. 4.You must give top-performers a reason to listen Rockstars have never had more options. You need to create a compelling employer value proposition. 5. Recruiting must be based on things that are predictive of success DNA is far more predictive than experience, education, or personality. 6. A top-performer at one company is not always a top-performer at another There are no shortcuts, even if they worked at your competitor. 7. Using your “gut” in recruiting is right 50% of the time But which 50%? Trust the process, and increase your accuracy to 90% or more. 8. To build a successful business, winning the war for talent must be your #1 priority You must invest at least 30% of your time on recruiting & retention. Connect with Jeff LinkedIn Twitter Strong Suit Strong Suit Podcast (iTunes) Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week’s episode is the third and final installment of our series in On-Demand Healthcare. Our guest today is Kelly Perdew, Managing General Partner of Moonshots Capital – an early stage angel syndicate that invests in early stage technology companies and leans in heavily on veteran founded companies. He is co-founder & Managing Partner at The DuMont Project – a consultative agency that helps accelerate the growth of direct to consumer brands. Prior to DuMont Project he was the CEO of Fastpoint Games, a venture-backed leading developer of live data-driven games for the fortune 500 brand set. Kelly earned a BS from the US Military Academy, West Point, a JD from the UCLA School of Law, and an MBA from the Anderson School at UCLA. Kelly served in the US Army as a Military Intelligence Officer and completed Airborne and Ranger training and is also an accomplished author and speaker on leadership. At Moonshot Capital Kelly and his cofounder Craig Cummings bring a disciplined approach to the investment process to identify companies with exceptional growth potential. They form close working relationships with the companies they back to help them achieve their critical milestones and frequently take on Board seats or formal advisory roles. As West Point graduates and veterans, they look to invest 50% of all deals in companies that are military veteran founded or run. In addition to all of this, Kelly was the winner of the 2nd season of NBC’s “The Apprentice”! In this Episode, Kelly speaks with Chuck and Healthbox Fund Associate Caroline Arenz about: Kelly’s fascinating background and experience After his experience as a company founder and CEO, how Kelly got into Angel and venture investing How Kelly defines a “moonshot” and his clear set of determining factors that allows him to make quick “no” decisions How Kelly got interested in On-Demand Healthcare and what led to his investment in PlushCare and why he considers PlushCare a “moonshot” What Kelly thinks thats healthcare companies could learn from taking ideas from other industries Of the 10 point checklist of selection criteria for companies Kelly invests in, which are the most important things he is looking for in the company founders he looks to invest in Links Connect with Kelly LinkedIn Twitter Website Connect with Moonshots Capital Twitter Website Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week we have Sameer Khanna, VP of Engineering at Pager on the program in the second part in our series around on-demand healthcare, specifically the use of AI in on-demand healthcare! Sameer holds a bachelors in Information Technology from Rochester Institute of Technology and a Masters of Computer Science from NYU. Prior to joining Pager, Sameer served as a key contributor at Lot18, successfully positioning the company as one of the largest wine e-commerce businesses. He then joined Viyet as CTO, and drove company revenue to 15x within 12 months with the construction of an e-commerce storefront, seller portal, and redesign of the marketplace website. In 2015, Sameer joined Pager as the Vice president of engineering. In this episode we cover: Sameer’s background and how he came to his role at Pager and how he dealt with the learning curve of getting into the healthcare space, coming from an e-commerce background How Sameer delineates the difference between Artificial Intelligence and Machine Learning What this version of Pager with artificial intelligence embedded looks like and how both patients and clinicians use it How Pager uses the data gathered to help the platform get smarter over time Where Sameer sees AI in healthcare going What in healthcare innovation currently is Sameer most excited about Links Connect with Sameer LinkedIn Connect with Pager Twitter Website Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week we have a great episode with Myra Hager of Baylor Scott & White Health and Dore Murphy formerly of Pager! Myra is the Director of Digital Health at Baylor Scott & White Health (BSWH) where she manages population health innovation strategy and project execution with a goal of achieving better population health by substantially improving outcomes, driving costs down, empowering their ACO and Health plans with digital solutions, as well as create opportunities for new business models to achieve population health. Dore was formerly the VP of Marketing at Pager, a company that is Reinventing the traditional doctor-patient experience by making quality care more convenient and accessible by sending a board-certified doctor to treat urgent care needs, at any location, summoned directly through their app. Prior to joining Pager, Dore led marketing at Sum and has a great experience working for a number of years at the New York Times In November of 2016, BSWH and Pager announced a partnership to bring Pager’s services to BSWH’s network in the Austin area In this episode we cover: What the partnership between Pager and Baylor Scott & White Health looks like and the parameters of the pilot How this collaboration came together Why Health Systems are the perfect partners for Pager and the types of services that will be offered Where Dore and Myra see Telehealth playing into the future of on-demand healthcare and how Baylor Scott & White Health has approached it How Pager and Baylor Scott & White Health think about maintaining efficiency in using clinicians for their on-demand healthcare offerings Where Dore and Myra see the future of on-demand healthcare going and how it will transform the way medicine is delivered now Links: Baylor Scott & White Health Twitter Website Pager Twitter Website Myra Hager LinkedIn Dore Murphy LinkedIn Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Today we have another great bonus episode featuring Glenn Winokur, Senior Advisor to Healthbox. Before Glenn came on board with Healthbox, he was Co-founder and CEO of Syapse, a company which he Incubated from an idea in a Stanford class to a market leading venture funded start-up that provides a precision medicine data platform enabling healthcare providers to use molecular profiling to diagnose and treat patients. Under Glenn’s leadership over an 8 year period, Syapse raised over $40m in venture funding. Prior to Syapse, Glenn was the CEO of Scalix and Chief Operating Officer of NetIQ, respectively. In addition to Healthbox, Glenn is an advisor to the University of Illinois, Stanford University, and UCSF. And with all this experience, Glenn has become an angel investor with investments including Puppet Labs, Cloud Sherpas (now part of Accenture), SchoolMessenger (now part of West Corp), Syapse, and Panthenon. In today’s episode we cover: Glenn’s background and role with Healthbox The story behind Glenn’s first investment and how did he arrived at the financial position to do so What draws Glenn to investing in Healthcare and why The key things Glenn wants to see if a company that he invests in How important Glenn’s background scaling companies and acting as CEO has been in his investing strategy What Glenn thinks entrepreneurs should consider about when raising from angels Connect with Glenn: LinkedIn Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week’s episode is the last episode in our series on new models of Primary Care! Our guest today, Michael Greeley, is a General Partner at Flare Capital Partners. Prior to co-founding Flare Capital Partners, Michael was the founding General Partner of Flybridge Capital Partners where he led the firm’s healthcare investments. Michael’s current and prior board seats include HealthVerity, Iora Health, Predilytics, TARIS Biomedical, and Welltok. Michael also serves on the Industry Advisory Board of the Cleveland Clinic and Boston Children’s Hospital, as well as serving on several other boards including the New England Investors’ Committee of Capital Innovation. Michael is most excited about the convergence of healthcare and information technologies and the profound opportunities to transform healthcare and writes about this and other topics on his blog www.ontheflyingbridge.com In this episode we cover: Michael’s background, work at Flare Capital, and his specific areas of investment interest How Flare Capital’s investment in Iora Health came together and what led him to say yes Michael’s general thoughts on entrepreneurs trying to build standalone primary care models and if he thinks this helps or could create more fragmentation in the system Where Michael sees the future of these New Models of Primary Care heading Michael’s thoughts around a blog post he wrote in that “if V1 of the Healthcare technology sector was triggered but the HITECH Act of 2009, the sector is now entering V2.0 where the commentary is focused on Artificial Intelligence and Virtual Reality solutions to make the healthcare system “capital light” to drive meaningful operating efficiencies from the significant investment of the past three years." What opportunities Michael believes will develop over the next few years If Michael sees a growth in early stage investment over the next few years or if he thinks we’ll see the percentage grow in Series B and later investments Why Michael thinks "Brands will become even more important” Links mentioned in the show: Steve Kraus at Bessemer Ventures https://www.bvp.com/team/stephen-kraus https://ontheflyingbridge.wordpress.com/2017/02/21/potential-next-steps-where-to-invest/ Connect with Michael: Twitter LinkedIn Blog Connect with Flare Capital Partners: Website Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Today’s episode is the second episode in our series on new models of Primary Care! Our guest today, Rushika Fernandopulle, MD, is Co-Founder and CEO of Iora Health. Rushika is a physician who has spent more than ten years involved in efforts to improve the quality of healthcare delivered to patients. He was the first Executive Director of the Harvard Interfaculty Program for Health Systems Improvement, and served as a Managing Director of the Advisory Board Company. He serves on the faculty and earned his MD and Masters in Health Policy from Harvard University and completed his clinical training at the Massachusetts General Hospital. In 2011, Rushika Co-founded Iora Health; Iora Health is building a different kind of health system to deliver high-impact, relationship-based care, helping patients manage their health and navigate the healthcare system. In this episode we cover: Rushika’s background and where his interest in improving healthcare delivery came from How the Iora Health model works What early iterations of the business model look like and what did Rushika try before arriving at what Iora is today As the company grows, how Iora Health continue to embrace innovation Iora Health has raised over $123M in funding to date; Rushika discusses the crucial inflection points in knowing when it was time to bring on new capital How Rushika responds to the criticism that these standalone primary care models could create more fragmentation in the system As Iora Health continues to expand and to raise money, besides capital, what Rushika looked for in his initial investors and what he looks for now in the later rounds Iora Health launched an Accountable Care agreement with Humana in Arizona and Washington for their Medicare Advantage population beginning in 2014. Rushika explains how Iora works with Humana and other insurers and where he sees possible opportunities moving forward What Rushika thinks about partnerships with health systems Where Rushika sees the future of these New Models of Primary Care heading Connect with Rushika: LinkedIn Twitter Connect with Iora Health: Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Today’s episode is the first in our new series on new models of Primary Care! Our first guest on the program is Niyum Gandhi, Executive Vice President and Chief Population Health Officer at Mount Sinai Health System. Niyum is responsible for leading Mount Sinai Health Partners and aligning clinical and economic transformations in support of Mount Sinai’s vision to be the leading population health manager in the region, as well as the best possible partner to the Health System’s broad physician community. His work includes fostering care management and clinical model redesign to ensure that high-value care is delivered by the Health System and its partners, and working with payers and self-funded employers to establish the new economic models that support the delivery of value-based care. Neil Patel, President of Healthbox, also joined this conversation. In this episode we cover: Niyum’s background, previous work around ACOs, and his role at Mount Sinai If Niyum thinks entrepreneurs trying to build standalone primary care models creates more fragmentation or less in the system How the Mount Sinai partnership with Oscar Health to open a primary-care clinic in Brooklyn came to be What success in this Oscar Health partnership looks like How Niyum is thinking about translating the benefits of this partnership to all of the Mt. Sinai patients Patient feedback and the process of scaling what Mt. Sinai have learned to date in this partnership If Niyum and Mt. Sinai feel these tight alignments with companies like Oscar Health is the way of the future The other areas of innovation and transformation at Mt. Sinai the Niyum is focused on Connect with Niyum: LinkedIn Twitter Connect with Mt. Sinai Health System: Website Twitter Connect with Oscar Health: Website News Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week we have a special episode recorded live from the 2017 Spring Healthbox Innovation Forum. The Healthbox innovation forum brings together some of the nation’s foremost leaders in healthcare and innovation from a variety of different organizations across the healthcare ecosystem. Our Spring Innovation forum was focused around “Redefining the Role of the Home in Healthcare”. The day consisted of presentations, an opening keynote, breakout activities, and an interactive and engaging panel discussion. At the conclusion of the event, Innovation Consulting Manager and host of Innovation Rising, Chuck Feerick, sat down with three great guests to get their takes on the day, what surprised them, and what they might start doing at their organizations based on what they heard at the Forum. Chip Blaufuss, Associate Vice President of Strategic Innovation for (HCA) LinkedIn Sheri Shapiro, Senior Vice President-Mergers, Acquisitions, and Partnership Development at Trinity Health LinkedIn Nimesh Jhaveri, Division Vice President, Walgreens LinkedIn Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week’s podcast features our interview with Adam Draper, Founder & Managing Director of Boost VC. Adam is a 2x entrepreneur and a 4th generation venture capitalist. He also co-founded Xpert Financial while still in his senior year at UCLA, which he then left in 2012, focusing on angel investing in which he invested in 20 companies, including Coinbase, Plangrid, and Practice Fusion, before starting Boost VC with this co-founder Brayton Williams. Launched in 2012, Boost VC is a specialized seed-stage accelerator that invests in blockchain and virtual reality startups. Twice a year Boost VC invests in 25+ startups. The three month accelerator program includes housing and office space in Silicon Valley. Boost’s Portfolio consists of 138 companies, who have raised over $125M after joining Boost VC. Adam joined Chuck Feerick and Healthbox President & COO Neil Patel to talk about Investing in Virtual Reality in this final part in our series on Virtual Reality in the healthcare space. A few of the topics we dive into in this episode include: Adam’s background, how he came to develop an interest in VR, and how close he is to developing an Ironman Suit How the Boost VC Model operates and how Adam helps companies in the VR space The concept of VR has been around for over 30 years, yet last year we saw more than $2B in VC money pour into the AR/VR, space continuing a trend we’ve seen over the past few years. Adam breaks down what is making this growth take off Why Adam thinks Healthcare is an underrated space Adams’ current healthcare investments and what makes him say “yes” or “no” Given Adam’s experience in gaming, entertainment, and retail, Adam discusses possibilities for VR in Healthcare The overall challenges that VR startups face and Adam’s advice for overcoming them, from an investor’s perspective What Adam thinks needs to happen for VR to go from a “cool” gadget to transformative technology Links: Innovation Rising Episode 19: Bonus - Accelerator/Studio Program Roundtable with Healthbox and Adam Draper of Boost VC Connect with Adam: LinkedIn Twitter Medium Connect with BoostVC Website Twitter Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Healthbox is a healthcare based accelerator, and Chuck and Adam discuss the differences in accelerators and sectors. Learn about different structures! We all try to help the best we can. https://www.healthbox.com/ https://www.linkedin.com/in/chuckfeerick https://twitter.com/chuckfeerick
This week’s podcast features our amazing interview with Matthew Stoudt, the CEO of AppliedVR. Matthew was previously cofounder and CEO of Outcast Media International (which was sold to Verifone), the McDonald’s New Ventures Entrepreneur in Residence, ran private equity at Triumph Capital Group and investment banking at DLJ, and earned his MBA from the Kellogg Graduate School of Management. Matthew joined us on the program to talk about the work he and his team are doing with applied VR in this second part of our series on Virtual Reality in the healthcare space. A few of the topics we dive into in this episode include: Matthew’s background and how he came to develop an interest in VR Matthew and AppliedVR’s work with Dr. Brennan Spiegel of Cedars-Sinai and how that relationship with Cedars-Sinai came into place How AppliedVR’s technology works to influence behavioral changes and how it plays in the behavioral health space How AppliedVR is using big data to help with treatment development and what kind of data they are looking at, how it is collected, and how AppliedVR is building on it over time to adaptively implement what the data is showing What Matthew says has been the hardest part of building the company and how he is overcoming that Matthew’s thoughts on how critical it is for entrepreneurs in the healthcare space to have close relationships with providers and healthcare systems, like Cedars-Sinai, as they build out their technology What has surprised Matthew most in his work to date Matthew’s thoughts overall on the future of VR Links: Connect with Matthew: LinkedIn Connect with AppliedVR Website Twitter Why Arianna Huffington Is Calm When Falling 500 Feet Better Than Opioids? Virtual Reality Could Be Your Next Painkiller AppliedVR Experiences Introduction Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
Our guest this week is Dr. Brennan Spiegel, Director of Health Services Research for Cedars-Sinai Health System and Professor of Medicine and Public Health at UCLA. Dr. Spiegel joins us on the program for this first part in our series around Virtual Reality in Healthcare. Dr. Spiegel directs the Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), a multidisciplinary team that investigates how digital health technologies, including wearable biosensors, smartphone applications, virtual reality, and social media, can strengthen the patient-doctor bond, improve outcomes, and save money. CS-CORE unites clinicians, computer scientists, engineers, statisticians and health services researchers to invent, test, and implement digital innovations for the clinical trenches, always focusing on the value of technology to patient and provider end-users. Dr. Spiegel has published numerous best-selling medical textbooks, editorials, and more than 160 articles in peer-reviewed journals. He is listed in the 2016 Onalytica "Top 100 Influencer" lists for digital health (#13) and virtual reality (#14). His digital health research has been featured by major media outlets, including NBC News, PBS, Forbes, Bloomberg, NPR, and Reuters. In this episode, we discuss: Dr. Spiegel’s background and how he came to develop an interest in VR? The work Dr. Spiegel is doing involving the patients; The outcomes of this work and how patients have reacted Why this kind of treatment works and what is going on in the brain that allows VR to be effective The "spotlight attention theory" The Moment of Cognitive Immersion and the Moment of Physiologic Immersion How a doctor can know which is the best type of VR treatment and the ideal immersive scenario for an individual patient The role of the “VR Pharmacy" How VR Therapy can be cost effective and what can be measured in a value-based setting What is next for VR in healthcare and what Dr. Spiegel sees happening in the next 1-2 years and in the next 10 years Links: Connect with Dr Spiegel: Website Twitter Virtual reality therapy treatments aim to reduce need for opioid use | Cronkite News Connect with Healthbox Follow us on Twitter and @ChuckFeerick Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
This week’s episode is another special Bonus Episode of Innovation Rising! I’m joined in the studio today by 3 great guests to discuss Accelerator/Studio programs, the benefits of these programs, and how companies can get the most from such an opportunity. Adam Draper from Boost VC joins us to talk about the Boost VC Accelerator and with me in the Studio from Healthbox is Matty Francis, Director of Innovation Consulting, and Kristen Lux, Outreach and Engagement Manager A few of the topics we get into in this episode: What an accelerator is How the Boost VC accelerator operates and what are the types of companies that should apply Are accelerators necessary? There are so many; what is the true value an accelerator provides beyond cash for equity? How the Healthbox Studio works and what are the types of companies that should apply What companies can do to make the most of their opportunity in the program Which companies should not go to an accelerator What startups should look for in an accelerator/Studio program How the Boost Accelerator and Healthbox Studio are complementary to one another Application information for both programs Links: Connect with Adam and Boost VC: Boost VC Boost VC Accelerator Application Adam on Twitter Connect with Healthbox Healthbox, Studio Information, and Application Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
Our guest today, Tressa Springmann, is the Vice President and Chief Information Officer for LifeBridge Health. Tressa joins us for this final episode in our series around Patient Identity in Value-Based Care. LifeBridge Health is a regional health care organization based in northwest Baltimore and its surrounding counties. LifeBridge Health consists of Sinai Hospital of Baltimore, Northwest Hospital, Carroll Hospital, Levindale Hebrew Geriatric Center and Hospital, LifeBridge Health & Fitness, hundreds of primary care and specialty physicians throughout the region, and many affiliated health-related partners. Prior to joining LifeBridge Health, Tressa was the Vice President and Chief Information Officer for the Greater Baltimore Medical Center. In addition, Tressa has a Masters of Administrative Science in Information Technology (MAS) from John Hopkins University and she currently serves as the chair of the technology committee of the Chesapeake Regional Information System for our Patients. A few of the topics we get into in this episode: An overview of Tressa’s background and how she came to her role at LifeBridge How LifeBridge is approaching the shift from FFS to value-based care and what are some of the larger trends or themes Tressa has seen across the healthcare industry with respect to value-based care How LifeBridge is approaching value-based care using innovation and the types of programs in place at LifeBridge to support innovation Why Tressa believes it is important for patients to own their own medical data LifeBridge’s approach to embracing digital health solution in the population health space and fostering innovation rather than stifling it How Tressa is involved with CRISP - the Chesapeake Regional Information System for our Patients – and what solutions like Health Information Exchanges are doing to forward value-based care Links: Connect with Tressa: LinkedIn Connect with LifeBridge: Website CRISP – Chesapeake Regional Information System for our Patients Connect with Healthbox Follow us on Twitter Follow me on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
On our episode this week, our interview features Chris Olsen, Co-Founder and General Partner at Drive Capital, for the second part of our series around Patient Identity in Value-Based Care! Chris is a Cincinnati-native, but previously was a partner at Sequoia Capital beginning in 2006 before co-founding Drive Capital in 2013. He joins Neil Patel, COO & President of Healthbox, and myself in this episode to discuss the move to Value Based Care and the investment opportunities this shift has created. In this episode, Chris, Neil, and I discuss: Chris’s background and how he came to start Drive Capital Why Chris is interested in the Value Based Care space and what about the companies he has invested in made him say “yes” As an investor who is not solely focused on the healthcare space, what are some of the things Chris needs to be comfortable with as he evaluates investments The advantages/disadvantages to having a broader investment focus Whether or not Chris thinks we are in a “bubble” as it relates to investment dollars in the venture capital space If 10 years down the road, companies were no longer focused on building toward value, what Chris believes they would be building toward What Chris thinks about the future of value-based healthcare models Connect with Chris: LinkedIn Twitter Connect with Drive Capital: Website Connect with Healthbox Follow us on Twitter Follow me on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
This week, our interview features Sean Lane, Founder of CrossCHX, for the first part of our series around Patient Identity in Value-Based Care. CrossChx is a platform and app that securely stores a user's medical history, prescriptions, and more all on a smartphone. A user can share their profile with any provider they want, eliminating paper forms while protecting a user's medical identity. In this episode, Sean and I discuss: Sean’s background and how he came to found CrossChx How the CrossChx platform works and how it solves a variety of healthcare inequities Why Patient Identity in Value-Based Care is an important problem to fix and why patients need to own their Identities How this moves us toward a value-based care model rather than traditional FFS How CrossChx is approaching building in AI and Machine learning and a “Digital assistant" to make sure physicians see the most important and relevant data Sean’s strategy around raising funds from both Midwest-based firms like Drive Capital in Columbus, OH, and from Khosla Ventures on the West Coast How the differing geography of CrossChx’s investors has played a role in the help they are able to provide Sean’s thoughts on the future of value-based healthcare models Connect with Sean Lane: LinkedIn Twitter Connect with CrossChx: Website Blog Twitter Connect with Healthbox Follow us on Twitter Follow me on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
This week we have a special episode that was recorded live SXSW in Austin. This year, SXSW featured a track on Healthcare from 3/10 - 3/14 which Neil Patel, Leland Brewster (www.healthbox.com/team), and I attended, as well as a number of the tech and innovation focused. We had a great time and learned a lot and in this episode we cover some of the important things we learned and emerging trends we saw. In this episode we discuss: New developments around genetic data and the importance of this data as it relates to gene editing The safety and infrastructure layers of data protecting and sharing Corporate Innovation: advice for both corporations and startups Corporate Innovation Resources from NESTA Better Collaboration with Corporates: Downloadable Tools for Startups Better collaboration with startups: Downloadable tools for corporates Better collaboration with startups: Tips for corporates and http://www.nesta.org.uk/sites/default/files/recomendation_for_corporates_2.pdf Better collaboration with corporates: Tips for startups and http://www.nesta.org.uk/sites/default/files/recomendationfor_startups_and_scale-ups.pdf Winning Together: A guide to successful Corporate-Startup Collaboration (PDF) Thoughts around “To Build in Health, Follow the $, Not the Patient" Resources: RIFLE Analysis from Khosla Improving targeting with meaningful quantitative analysis “Market Rifle” – what market segments should we be in? “Account Rifle” – which accounts should we target? “Channel Rifle” – what channel strategy, what partners? http://www.khoslaventures.com/rifle-framework http://www.khoslaventures.com/project-rifle How Healthbox uses the Radical Candor framework from Kim Scott and Christa Quarles Radical Candor Website Book Keynotes: Collaborative Innovation in the Digital Health Age Clay Johnston Dell Medical School at UT Austin Ginni Rommety IBM Corporation Alex Gorsky Johnson & Johnson Mark Cuban Blog Maverick Chris Sacca Lowercase Capital
My guest this week is Yumin Choi, Managing Director of Bain Capital Ventures Healthcare team. Yumin joined Bain's Boston team last year after ten years culminating as a General Partner at HLM Venture Partners. At HLM he led a variety of investments across healthcare IT and services sectors, serving as board director for AbleTo, mPulse Mobile, Oceans Healthcare, Payspan (acquired by Primus Capital), Spinal Kinetics, and Vets First Choice. Yumin has a really interesting background... born in Seoul, South Korea, lived in Japan as a child and moved to Hawaii at age 10 where he attended the Punahou School, President Obama’s alma mater. He's an investor and mentor in several healthcare accelerators, including Blueprint Health, Healthbox, Startup Health, Rock Health, and 500 Startups. Yumin serves with me on the board of the New England Venture Capital Association, and on the board of overseers for the Boston Symphony Orchestra, and the oversight committee for Boston University’s Coulter Foundation. He also served as a lecturer in the Gordon Institute at Tufts University, where he taught entrepreneurial finance. I think my conversation with Yumin about the job of being a VC is probably the most illuminating I’ve had to date, focusing on the importance of building a network, looking for patterns in the dots of what can be hundreds of near misses and good ideas below the threshold of Yes, and staying open to opportunities regardless of their source or pedigree. Our second segment, though, is about the single event that probably shaped Yumin’s views on the value of healthcare innovation more than any other... his own diagnosis with cancer at age 31, and a subsequent treatment regime that - all by itself - almost killed him. This is not the usual blah blah about relationships in venture, folks, try as we always do to avoid that. My conversation with Yumin was about his journey to understand why what he was doing mattered, and I was inspired by him and his story in a way I hope you will be too. How Hard Can It Be is sponsored by G20 Ventures, early traction capital for East Coast enterprise tech startups, backed by the power and expertise of 20 of the Northeast's most accomplished entrepreneurs. G20 Ventures... People first. How Hard Can It Be is also sponsored by Actifio, the world’s leading Enterprise Data-as-a-Service platform. Deliver your data just like your applications and infrastructure... as a service available instantly, anywhere. For hybrid cloud, faster DevOps, and better business resiliency, Actifio is Radically Simple.
Innovation Rising Episode 14: David Cohn of Regroup Therapy and Bob Saunders of OCA Ventures (Part 2) In this week’s special interview I am rejoined in the studio by 3 guests to discuss digital innovation in healthcare around Behavioral Health: David Cohn, CEO, Founder of Regroup Therapy, Bob Saunders, General Partner at OCA Ventures, and my co-host for this episode, Neil Patel, President and COO of Healthbox. This is part 2 of a 2-part interview with Bob and David! Make sure to go back and listen to Part 1 if you missed that episode! In the interview, we discuss: How having OCA and Bob as an investor has been helpful to David and some examples Lessons David would share with other entrepreneurs about making a deal with large customers and factors that led to that success David’s lessons learned from deals that didn’t go through David’s thoughts on the advantages of starting a company in Chicago that most entrepreneurs overlook Bob and OCA Venture’s outlook on the advantages of investing in the midwest that most investors don't think about Where Bob sees the intersection of Behavioral therapy and digital health space heading in the future Connect with David: LinkedIn Twitter Connect with Bob: LinkedIn Learn more about Regroup Therapy Website Twitter Learn more about OCA Ventures Website Twitter Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
Welcome back to Part 2 of our special bonus episodes featuring a recap and insights from the 2017 HIMSS Conference that happened in Orlando last week. The HIMSS Conference brings together IT vendors, providers, payers, investors, and key thought leaders in the Healthcare IT space. Some 40,000 participants attended the lectures, panels, meetings and exhibits. This special 2-part set of bonus episodes features interviews from many of the Healthbox team that attended the conference. This second episode includes interviews with: Justin Gernot - VP Business Development Caroline Arenz - Associate, Fund Management Leland Brewster - Manager, Fund Management Matty Francis - Director, Innovation Consulting Enjoy this episode and let us know any questions you have or Tweet us about your experience at HIMSS 2017! Links Mentioned in this Episode: HIMSS Conference HX360 Innovation Leaders Program- Betting on Collaboration for the Future of Healthcare Evaluating the Impact of Interoperability on Healthcare Outcomes: Pilot Study Microsoft announces new health-focused initiatives and solutions, and emerging strategic research partnership with UPMC University of North Carolina Center for Health Innovation and AARP Collaborate on Digital Health Solutions for the 50+ Population Moving Patient Data Is Messy, But Blockchain Is Here to Help Wellpepper Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to this episode on iTunes, SoundCloud, or Libsyn
This week we have a special bonus episode featuring a recap and insights from the 2017 HIMSS Conference that happened in Orlando last week. The HIMSS Conference brings together IT vendors, providers, payers, investors, and key thought leaders in the Healthcare IT space. Some 40,000 participants attended the lectures, panels, meetings and exhibits. This special 2-part set of bonus episodes features interviews from many of the Healthbox team that attended the conference. This first episode includes interviews with: Dr. Eric Louie - Chief Medical Officer Blake Miner - Associate, Innovation Consulting Emily Wengel - Manager Chuck Feerick - Manager, Innovation Consulting, Innovation Rising Podcast host Enjoy this episode and let us know any questions you have or Tweet us about your experience at HIMSS 2017! Links Mentioned in this Episode: HIMSS Conference Keynote Speaker: Ginni Rometty Innovation is Heartbeat of Healthcare AHIP Innovation Lab HX360 Innovation Leaders Program: UPMC-Journey to an Innovation Hub Beyond Verbal Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
In this week’s special interview I am joined in the studio by 3 guests to discuss digital innovation in healthcare around Behavioral Health: David Cohn, CEO, Founder of Regroup Therapy, Bob Saunders, General Partner at OCA Ventures, and my co-host for this episode, Neil Patel, President and COO of Healthbox. This is part 1 of a 2-part interview with Bob and David so make sure to listen to part 2 next week! In the interview, we discuss: David’s background and where the idea for Regroup come from Why David chose a “health system/provider model” over the direct to consumer model Bob’s background and specific focus at OCA Ventures What attracts Bob to investments in the Behavioral Health space How Bob approaches being involved with the companies he invests in What David was looking for in an investor The advantages about starting a company in Chicago that most entrepreneurs overlook Connect with David: LinkedIn Twitter Connect with Bob: LinkedIn Learn more about Regroup Therapy Website Twitter Learn more about OCA Ventures Website Twitter Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
In this special episode of Innovation Rising, I sat down with Healthbox’s Chief Medical Officer, Eric Louie, to talk about his takeaways from the Exponential Medicine conference which he attended back in October. There were some fascinating topics in covered in this podcast, including: What was the premise of the Exponential Medicine conference? What is the Quantified Self? How “Insideables” work The latest news and research on Genomics and gene editing Peter Diamandis 4 P’s of the cornerstones of personalized medicine “The business of health as the business of information science” The future of physicians Links mentioned in the show: Exponential Medicine Conference Peter Diamandis: Books Bold Singularity University Profusa Human Longevity Institute: Craig Venter Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
Federal court orders ISPs to block piracy sites, Amazon Prime Video launches in Australia and what it takes to become a licenced drone pilot, we take a look at Apple’s new AirPods, Netgear’s new Orbi home wi-fi system, the Under Armour HealthBox and the Tech Guide Help Desk.
In this special episode of Innovation Rising, I had the pleasure of sitting down with Stephen Hunter, Physical Therapy Administrator for Intermountain Healthcare Physical Therapy and founder of ROMS, which stands for Rehab Outcomes Management System, which he developed at Intermountain Healthcare in 2000 and which was accepted to go through the Intermountain Foundry Program in 2015. Stephens passion for the startup is palpable and I had a great time in my conversation with him. Stephen has been with Intermountain for over 31 years where he is the active administrator over 11 outpatient orthopedic PT clinics and a practicing clinician. Stephen is the Author and co-author to several articles establishing the value of physical therapy and has his Clinical Doctorate of Physical Therapy from the University of Utah. In 2014, Intermountain Healthcare launched their Foundry Program in partnership with Healthbox. The Foundry is a part-time program providing resources and guidance to vet the business aspects of employee ideas that could either benefit Intermountain internally or have additional commercialization potential outside of the system. For more details on setup, genesis, and background of Intermountain’s innovation focus, have a listen to our previous episode with Jeremy Porter, the Director of Business Development at Intermountain Healthcare. In this episode Stephen and I discuss: What ROMS is today and how it works How Stephen sees his product making an impact on the industry and improving the lives of patients Stephen’s experience in the Intermountain Foundry Program and what he got out of it Stephen’s thoughts around how being a physical therapist himself helped him in creating ROMS What advice Stephen has for entrepreneurs and intrapreneurs who don’t have access to such dedicated resources as the Intermountain Foundry: Who would be other people internal innovators should look to add to their team? How can internal innovators obtain the executive support they need? How the ROMS solution helps achieve impactful results in a value based care model What obstacles Stephen faces as he continues to build ROMS as an employee-innovator What Stephen is most excited about in healthcare innovation right now Connect with Stephen: LinkedIn ROMS Learn more about Intermountain Health Website Twitter Links mentioned in the show: Innovation at Intermountain Episode 2 with Jeremy Porter Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn
On this week’s episode of Innovation Rising, we sat down with Jeremy Porter, Director of Business Development at Intermountain Healthcare to discuss what Internal Health System Innovation looks like for his organization, Intermountain Healthcare, based in Salt Lake City, with multiple locations across the state of Utah. Jeremy and his team look to leverage existing assets, patents, technology, and business models to support Intermountain's core mission and values while identifying additional revenue opportunities. Innovation and Growth at Intermountain Healthcare supports the ideation, creation, and adoption of new solutions that will improve quality and service while making care more affordable. Intermountain harness internal creativity and external disruption to continually improve outcomes, longevity, and overall wellbeing. One of the avenues supporting employee innovation is the Intermountain Foundry. Launched in 2014 in partnership with Healthbox, the Foundry is a part-time program providing resources and guidance to vet the business aspects of employee ideas that could either benefit Intermountain internally or have additional commercialization potential outside of the system. In this episode we discuss: How innovation became a priority at Intermountain Healthcare The characteristics of Intermountain Healthcare as a system that make it conducive to innovation The various innovation programs at Intermountain The specific needs that Intermountain was seeking to fulfill through the development of the Foundry Program How Intermountain uses internal mentors to help the Foundry Participants How Intermountain's entrepreneurs have benefited from the mentoring process If Jeremy was to establish a dream program for innovation at Intermountain, without staffing or capital constraints, what are some things he would like to try? What other health systems Jeremy admires as leaders in healthcare innovation and why he feels this way Which digital health startups Jeremy is particularly impressed with What is exciting Jeremy most about healthcare innovation right now Connect with Jeremy: LinkedIn Learn more about Intermountain Health Website Twitter Links mentioned in the show: Transforming Healthcare through innovation at Intermountain Healthbox to help entrepreneurs inside and outside Intermountain get to “yes” Intermountain Foundry Rewards Employee Innovation at Inaugural Event Connect with Healthbox Follow us on Twitter Subscribe and leave a review in iTunes Have guest suggestions or topic ideas for the podcast? Send them to us at ideas@healthbox.com Listen to his episode on iTunes, SoundCloud, or Libsyn Check out the Blog Post for this episode
Welcome to the Innovation Rising Podcast, presented by Healthbox! This episode is a preview of the exciting episodes we have coming in the future. Subscribe and stay tuned for our first episodes which will be launching in the next couple of weeks!
Thea Polancic is a passionate advocate for the power of business as a force for good in the world. She is the Founder and Chair of the Chicago Chapter of Conscious Capitalism - a movement dedicated to elevating humanity through business, founded by John Mackey, CEO of Whole Foods Market. The Chicago Chapter is the first in North America, and in less than 18 months it has grown to more than 1,100 members. Under her leadership, the Chicago Chapter produces programs for the general public and private events for senior executives who are committed to leading organizations that are both purposeful and unapologetically profit-driven. As a result of her efforts, the international Conscious Capitalism Annual Conference has taken place in Chicago for the past two years. Thea is also the Managing Partner of ClearSpace, LLC, a consulting firm that helps CEOs transform themselves, their teams and organizations to meet the challenges of the future and grow and thrive. Over the past 15 years, Thea has worked closely with many senior leadership teams to grow organizations with a higher purpose, creating value for all stakeholders, developing servant leaders, and having healthy, values-based cultures. Her firm’s clients include organizations large and small across the country. She is a mentor to Chicago accelerators TechStars Chicago, Healthbox and The Impact Engine and the Conscious Venture Lab in Maryland. Thea is sought-after speaker on leadership and the future of business. Web - www.Clearspace.net Twitter - @tdpolancic LinkedIn - https://www.linkedin.com/in/theadurfeepolancic Summary & Ideas for Action In this interview, Thea covers the concept that consciousness and profit are compatible. Older executives may need to examine consciousness; younger executives may need to open their consciousness to embrace profit. Purpose is an intentional combination of consciousness and profit that necessitates a great business model, great leaders, and engaged stakeholders—the suppliers, the customers, the board, shareholders, and owners, and the employees of the organization. The growth is a journey, not an endpoint. The CEO is key to the purpose. Purpose spreads from the CEO down through the organization. If the CEO is not engaged in the purpose, the organization cannot prop it up. If the CEO sustains the purpose, then so may the organization. Key Takeaways [5:46] Will big business save the world? McDonald’s is the largest employer of teenagers on the planet. To make a difference for teenagers, you should go talk to McDonald’s. [6:58] My personal purpose is in the form of a promise: By the year 2030, business creates a world of beauty, prosperity, and happiness. [8:21] The world is a complex, ambiguous place. In uncertain, complex environments there is a specific kind of leadership that is more effective, which starts with a long-term perspective. [14:15] How do you teach that it’s OK to be unapologetically capitalist and profit-driven? [17:27] The need for purpose is on the rise and is moving mainstream quickly. [22:05] This is a journey, not an endpoint. It starts with the CEO’s internal work. A CEO who is not the authentic driver of the purpose will undermine it. [29:50] Leaders must match the intellectual valuing of mistakes, failure, and the challenges of the climb with the emotional capacity to be compassionate for themselves and their teammates, and create an environment of emotional safety inside of which risk taking can happen. Quotable Quotes “What we want is that caring and accountability.” “Doing business in this way is ultimately one of the few remaining sources of competitive advantage that you’re going to have.” “Have a stakeholder value creation model, not just a shareholder or owner value creation model.” Books Mentioned on the Show Creativity, Inc.: Overcoming the Unseen Forces That Stand in the Way of True Inspiration Leaders Eat Last Mindset: The New Psychology for Success The Fifth Discipline: The Art and Practice of The Learning Organization
This is going to be sort of a different podcast because I felt like this was going to be the best medium for this discussion and why I am not recommending people buy HealthBox (mostly the health band at this point) and why it isn't a great fit for Eat To Perform goals.
exchanges by Exciting Commerce | E-Commerce | Digitalisierung | Online - Handel
Jochen Krisch und Marcel Weiß nehmen die Übernahme der Mysportgroup und die Healthbox von Under Armour zum Anlass und widmen sich in den neuesten Exchanges dem Sportmarkt, in den sowohl händlerseitig als auch herstellerseitig Bewegung kommt. Links zu den Themen: http://excitingcommerce.de/2016/01/18/exchanges-123-wer-punktet-im-sportmarkt/
© 2020-2025 Ivy Podcast Discovery LLC
